Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-Q
 
(Mark One)
 	 	 	
þ	 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the quarterly period ended March 31, 2011
Or
 	 	 	
o	 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934	
For the transition period from                      to                     
Commission file number: 001-31719
 
Molina Healthcare, Inc.
(Exact name of registrant as specified in its charter)
 	 	 	
Delaware	 	13-4204626	
(State or other jurisdiction of	 	(I.R.S. Employer	
incorporation or organization)	 	Identification No.)	
 	 	 	
200 Oceangate, Suite 100	 	 	
Long Beach, California	 	90802	
(Address of principal executive offices)	 	(Zip Code)	
(562) 435-3666
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  o  No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 	 	 	 	 	 	 	
Large accelerated filer o	 	Accelerated filer þ	 	Non-accelerated filer o	 	Smaller reporting company o	
 	 	 	 	(Do not check if a smaller reporting company)	 	 	
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o  No  þ
The number of shares of the issuer’s common stock outstanding as of April 21, 2011 was approximately 30,570,400.

 

 
MOLINA HEALTHCARE, INC.
Index
 	 	 	 	 	 	 	 	 	
Part I — Financial Information

Item 1. Financial Statements	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Balance Sheets as of March 31, 2011 (unaudited) and December 31, 2010	 	 	3	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Statements of Income for the three months ended March 31, 2011 and 2010 (unaudited)	 	 	4	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Statements of Comprehensive Income for the three months ended March 31, 2011 and 2010 (unaudited)	 	 	5	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Consolidated Statements of Cash Flows for the three months ended March 31, 2011 and 2010 (unaudited)	 	 	6	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Notes to Consolidated Financial Statements (unaudited)	 	 	7	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	 	 	20	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 3. Quantitative and Qualitative Disclosures About Market Risk	 	 	40	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 4. Controls and Procedures	 	 	40	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Part II — Other Information

Item 1. Legal Proceedings	 	 	41	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 1A. Risk Factors	 	 	41	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Item 6. Exhibits	 	 	41	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
Signatures	 	 	42	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	
 Exhibit 31.1	
 Exhibit 31.2	
 Exhibit 32.1	
 Exhibit 32.2	

2

Table of Contents
PART I — FINANCIAL INFORMATION
 	 	 	
Item 1:	 	Financial Statements.	
MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
 	 	 	 	 	 	 	 	 	
 	 	March 31,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(Amounts in thousands,	 	
 	 	except per-share data)	 	
 	 	(Unaudited)	 	 	 	 	 	
ASSETS
	
Current assets:	 	 	 	 	 	 	 	 	
Cash and cash equivalents	 	$	463,792	 	 	$	455,886	 	
Investments	 	 	337,514	 	 	 	295,375	 	
Receivables	 	 	170,418	 	 	 	168,190	 	
Deferred income taxes	 	 	15,395	 	 	 	15,716	 	
Prepaid expenses and other current assets	 	 	28,608	 	 	 	22,772	 	
 	 	 	 	 	 	 	
Total current assets	 	 	1,015,727	 	 	 	957,939	 	
Property and equipment, net	 	 	107,757	 	 	 	100,537	 	
Deferred contract costs	 	 	37,891	 	 	 	28,444	 	
Intangible assets, net	 	 	98,048	 	 	 	105,500	 	
Goodwill and indefinite-lived intangible assets	 	 	212,484	 	 	 	212,228	 	
Auction rate securities	 	 	20,187	 	 	 	20,449	 	
Restricted investments	 	 	49,307	 	 	 	42,100	 	
Receivable for ceded life and annuity contracts	 	 	24,155	 	 	 	24,649	 	
Other assets	 	 	17,598	 	 	 	17,368	 	
 	 	 	 	 	 	 	
 	 	$	1,583,154	 	 	$	1,509,214	 	

LIABILITIES AND STOCKHOLDERS’ EQUITY
	
Current liabilities:	 	 	 	 	 	 	 	 	
Medical claims and benefits payable	 	$	351,382	 	 	$	354,356	 	
Accounts payable and accrued liabilities	 	 	113,697	 	 	 	137,930	 	
Deferred revenue	 	 	143,273	 	 	 	60,086	 	
Income taxes payable	 	 	7,746	 	 	 	13,176	 	
 	 	 	 	 	 	 	
Total current liabilities	 	 	616,098	 	 	 	565,548	 	
Long-term debt	 	 	165,354	 	 	 	164,014	 	
Deferred income taxes	 	 	17,462	 	 	 	16,235	 	
Liability for ceded life and annuity contracts	 	 	24,155	 	 	 	24,649	 	
Other long-term liabilities	 	 	19,580	 	 	 	19,711	 	
 	 	 	 	 	 	 	
Total liabilities	 	 	842,649	 	 	 	790,157	 	

Stockholders’ equity:	 	 	 	 	 	 	 	 	
Common stock, $0.001 par value; 80,000 shares authorized; outstanding: 30,552 shares at March 31, 2011 and 30,309 shares at December 31, 2010	 	 	31	 	 	 	30	 	
Preferred stock, $0.001 par value; 20,000 shares authorized, no shares issued and outstanding	 	 	—	 	 	 	—	 	
Additional paid-in capital	 	 	255,803	 	 	 	251,627	 	
Accumulated other comprehensive loss	 	 	(2,309	)	 	 	(2,192	)	
Retained earnings	 	 	486,980	 	 	 	469,592	 	
 	 	 	 	 	 	 	
Total stockholders’ equity	 	 	740,505	 	 	 	719,057	 	
 	 	 	 	 	 	 	
 	 	$	1,583,154	 	 	$	1,509,214	 	
 	 	 	 	 	 	 	
See accompanying notes.

3

Table of Contents
MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF INCOME
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands, except per-share data)
(Unaudited)	 	
Revenue:	 	 	 	 	 	 	 	 	
Premium revenue	 	$	1,081,438	 	 	$	965,220	 	
Service revenue	 	 	36,674	 	 	 	—	 	
Investment income	 	 	1,594	 	 	 	1,521	 	
 	 	 	 	 	 	 	
Total revenue	 	 	1,119,706	 	 	 	966,741	 	
 	 	 	 	 	 	 	
Expenses:	 	 	 	 	 	 	 	 	
Medical care costs	 	 	913,532	 	 	 	822,816	 	
Cost of service revenue	 	 	31,221	 	 	 	—	 	
General and administrative expenses	 	 	94,436	 	 	 	78,880	 	
Premium tax expenses	 	 	36,550	 	 	 	34,546	 	
Depreciation and amortization	 	 	12,667	 	 	 	10,061	 	
 	 	 	 	 	 	 	
Total expenses	 	 	1,088,406	 	 	 	946,303	 	
 	 	 	 	 	 	 	
Operating income	 	 	31,300	 	 	 	20,438	 	
Interest expense	 	 	3,603	 	 	 	3,357	 	
 	 	 	 	 	 	 	
Income before income taxes	 	 	27,697	 	 	 	17,081	 	
Provision for income taxes	 	 	10,309	 	 	 	6,491	 	
 	 	 	 	 	 	 	
Net income	 	$	17,388	 	 	$	10,590	 	
 	 	 	 	 	 	 	
Net income per share:	 	 	 	 	 	 	 	 	
Basic	 	$	0.57	 	 	$	0.41	 	
 	 	 	 	 	 	 	
Diluted	 	$	0.56	 	 	$	0.41	 	
 	 	 	 	 	 	 	
Weighted average shares outstanding:	 	 	 	 	 	 	 	 	
Basic	 	 	30,392	 	 	 	25,646	 	
 	 	 	 	 	 	 	
Diluted	 	 	30,838	 	 	 	25,837	 	
 	 	 	 	 	 	 	
See accompanying notes.

4

Table of Contents
MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	
 	 	March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(Amounts in thousands)	 	
 	 	(Unaudited)	 	
Net income	 	$	17,388	 	 	$	10,590	 	
Other comprehensive (loss) gain, net of tax:	 	 	 	 	 	 	 	 	
Unrealized (loss) gain on investments	 	 	(117	)	 	 	128	 	
 	 	 	 	 	 	 	
Other comprehensive (loss) gain	 	 	(117	)	 	 	128	 	
 	 	 	 	 	 	 	
Comprehensive income	 	$	17,271	 	 	$	10,718	 	
 	 	 	 	 	 	 	
See accompanying notes.

5

Table of Contents
MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	
 	 	March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(Dollars in thousands)	 	
 	 	(Unaudited)	 	
Operating activities:	 	 	 	 	 	 	 	 	
Net income	 	$	17,388	 	 	$	10,590	 	
Adjustments to reconcile net income to net cash provided by operating activities:	 	 	 	 	 	 	 	 	
Depreciation and amortization	 	 	18,094	 	 	 	10,061	 	
Deferred income taxes	 	 	1,619	 	 	 	3,094	 	
Stock-based compensation	 	 	4,064	 	 	 	2,136	 	
Non-cash interest on convertible senior notes	 	 	1,340	 	 	 	1,243	 	
Amortization of premium/discount on investments	 	 	1,644	 	 	 	259	 	
Amortization of deferred financing costs	 	 	503	 	 	 	344	 	
Unrealized gain on trading securities	 	 	—	 	 	 	(540	)	
Loss on rights agreement	 	 	—	 	 	 	493	 	
Tax deficiency from employee stock compensation	 	 	(264	)	 	 	(353	)	
Changes in operating assets and liabilities:	 	 	 	 	 	 	 	 	
Receivables	 	 	(2,168	)	 	 	8,054	 	
Prepaid expenses and other current assets	 	 	(8,142	)	 	 	(668	)	
Medical claims and benefits payable	 	 	(2,974	)	 	 	11,657	 	
Accounts payable and accrued liabilities	 	 	(25,796	)	 	 	15,134	 	
Deferred revenue	 	 	84,172	 	 	 	(90,664	)	
Income taxes	 	 	(5,430	)	 	 	2,935	 	
 	 	 	 	 	 	 	
Net cash provided by (used in) operating activities	 	 	84,050	 	 	 	(26,225	)	
 	 	 	 	 	 	 	
Investing activities:	 	 	 	 	 	 	 	 	
Purchases of equipment	 	 	(14,941	)	 	 	(5,976	)	
Purchases of investments	 	 	(104,984	)	 	 	(49,439	)	
Sales and maturities of investments	 	 	61,275	 	 	 	52,967	 	
Net cash paid in business combinations	 	 	(3,253	)	 	 	(2,430	)	
Increase in deferred contract costs	 	 	(9,635	)	 	 	—	 	
Increase in restricted investments	 	 	(7,207	)	 	 	(656	)	
Change in other noncurrent assets and liabilities	 	 	(937	)	 	 	426	 	
 	 	 	 	 	 	 	
Net cash used in investing activities	 	 	(79,682	)	 	 	(5,108	)	
 	 	 	 	 	 	 	
Financing activities:	 	 	 	 	 	 	 	 	
Proceeds from employee stock plans	 	 	2,462	 	 	 	—	 	
Excess tax benefits from employee stock compensation	 	 	1,076	 	 	 	113	 	
 	 	 	 	 	 	 	
Net cash provided by financing activities	 	 	3,538	 	 	 	113	 	
 	 	 	 	 	 	 	
Net increase (decrease) in cash and cash equivalents	 	 	7,906	 	 	 	(31,220	)	
Cash and cash equivalents at beginning of period	 	 	455,886	 	 	 	469,501	 	
 	 	 	 	 	 	 	
Cash and cash equivalents at end of period	 	$	463,792	 	 	$	438,281	 	

Supplemental cash flow information:	 	 	 	 	 	 	 	 	
Cash paid during the period for:	 	 	 	 	 	 	 	 	
Income taxes	 	$	14,068	 	 	$	91	 	
 	 	 	 	 	 	 	
Interest	 	$	269	 	 	$	142	 	
 	 	 	 	 	 	 	
Schedule of non-cash investing and financing activities:	 	 	 	 	 	 	 	 	
Retirement of common stock used for stock-based compensation	 	$	3,161	 	 	$	1,526	 	
 	 	 	 	 	 	 	
Details of business combinations adjustments:	 	 	 	 	 	 	 	 	
Increase in fair value of assets acquired	 	$	(256	)	 	$	—	 	
Decrease in fair value of liabilities assumed	 	 	(1,045	)	 	 	—	 	
Decrease in payable to sellers	 	 	(1,952	)	 	 	(2,430	)	
 	 	 	 	 	 	 	
Net cash paid in business combinations	 	$	(3,253	)	 	$	(2,430	)	
 	 	 	 	 	 	 	
See accompanying notes.

6

Table of Contents
MOLINA HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
March 31, 2011
1. Basis of Presentation
Organization and Operations
Molina Healthcare, Inc. provides quality and cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals, and to assist state agencies in their administration of the Medicaid program.
Our Health Plans segment comprises health plans in California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin. As of March 31, 2011, these health plans served approximately 1.6 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization, or HMO.
Our Molina Medicaid Solutions segment, which we acquired during the second quarter of 2010, provides business processing and information technology development and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, and West Virginia, and drug rebate administration services in Florida.
Consolidation and Interim Financial Information
The consolidated financial statements include the accounts of Molina Healthcare, Inc. and all majority owned subsidiaries. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the interim periods presented have been included; such adjustments consist of normal recurring adjustments. All significant intercompany balances and transactions have been eliminated in consolidation. The consolidated results of operations for the current interim period are not necessarily indicative of the results for the entire year ending December 31, 2011. Financial information related to subsidiaries acquired during any year is included only for the period subsequent to their acquisition.
The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended December 31, 2010. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in the December 31, 2010 audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our December 31, 2010 audited financial statements.
Reclassifications
We have reclassified certain amounts in the 2010 consolidated statement of cash flows to conform to the 2011 presentation.
2. Significant Accounting Policies
Income Taxes
The provision for income taxes is determined using an estimated annual effective tax rate, which is generally greater than the U.S. federal statutory rate primarily because of state taxes. The effective tax rate may be subject to fluctuations during the year as new information is obtained. Such information may affect the assumptions used to estimate the annual effective tax rate, including factors such as the mix of pretax earnings in the various tax jurisdictions in which we operate, valuation allowances against deferred tax assets, the recognition or derecognition of tax benefits related to uncertain tax positions, and changes in or the interpretation of tax laws in jurisdictions where we conduct business. We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities, along with net operating loss and tax credit carryovers.

7

Table of Contents
The total amount of unrecognized tax benefits was $11.0 million as of March 31, 2011, and $11.0 million as of December 31, 2010. Approximately $8.4 million of the unrecognized tax benefits recorded at March 31, 2011, relate to a tax position claimed on a state refund claim that will not result in a cash payment for income taxes if our claim is denied. The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate was $7.8 million as of March 31, 2011. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities will decrease by approximately $0.5 million due to the expiration of statute of limitations.
Our continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. As of March 31, 2011, and December 31, 2010, we had accrued $88,000 and $82,000, respectively, for the payment of interest and penalties.
Deferral of Service Revenue and Cost of Service Revenue — Molina Medicaid Solutions Segment
The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of three elements of service. The first of these is the design, development and implementation, or DDI, of a Medicaid Management Information System, or MMIS. The second element, following completion of the DDI element, is the operation of the MMIS under a business process outsourcing, or BPO, arrangement. While providing BPO services, we also provide the state with the third contracted element — training and IT support and hosting services (training and support).
Because they include these three elements of service, our Molina Medicaid Solutions contracts are multiple-element arrangements. The following discussion applies to our contracts with multiple elements entered into prior to January 1, 2011, before our prospective adoption of  ASU No. 2009-13, Revenue Recognition (ASC Topic 605) — Multiple-Deliverable Revenue Arrangements .  See  discussion below on page 9.
For those contracts entered into prior to January 1, 2011, we have no vendor specific objective evidence, or VSOE, of fair value for any of the individual elements in these contracts, and at no point in the contract will we have VSOE for the undelivered elements in the contract. We lack VSOE of the fair value of the individual elements of our Molina Medicaid Solutions contracts for the following reasons:
 	•	 	Each contract calls for the provision of its own specific set of products and services, which vary significantly between contracts; and	

 	•	 	The nature of the MMIS installed varies significantly between our older contracts (proprietary mainframe systems) and our newer contracts (commercial off-the-shelf technology solutions).	
The absence of VSOE within the context of a multiple element arrangement requires us to delay recognition of any revenue for an MMIS contract until completion of the DDI phase of the contract. As a general principle, revenue recognition will therefore commence at the completion of the DDI phase, and all revenue will be recognized over the period that BPO services and training and support services are provided. Consistent with the deferral of revenue, recognition of all direct costs (such as direct labor, hardware, and software) associated with the DDI phase of our contracts is deferred until the commencement of revenue recognition. Deferred costs are recognized on a straight-line basis over the period of revenue recognition.
Provisions specific to each contract may, however, lead us to modify this general principle. In those circumstances, the right of the state to refuse acceptance of services, as well as the related obligation to compensate us, may require us to delay recognition of all or part of our revenue until that contingency (the right of the state to refuse acceptance) has been removed. In those circumstances we defer recognition of any revenue at risk (whether DDI, BPO services, or training and support services) until the contingency has been removed. In these circumstances, we would also defer recognition of incremental direct costs (such as direct labor, hardware, and software) associated with the contract (whether DDI, BPO services, or training and support services) on which revenue recognition is being deferred. Such deferred contract costs are recognized on a straight-line basis over the period of revenue recognition.
For all new or materially modified revenue arrangements with multiple elements entered into on or after January 1, 2011, which we expect will consist of contracts entered into by our Molina Medicaid Solutions segment, we will apply the guidance contained in ASU No. 2009-13. For these arrangements, we will allocate total arrangement consideration to the elements of the arrangement, which are expected to be DDI, BPO, and training and support, because this is consistent with the current elements included in our Molina Medicaid Solutions contracts. The arrangement allocation will be performed using the relative selling-price method. When determining the selling price of each element, we will first attempt to use VSOE if available. If VSOE is not available, we will attempt to use third-party evidence, or TPE, of vendors selling similar services to similarly situated customers on a standalone basis, if available. If neither VSOE nor TPE are available, we will use our best estimate of the selling price for each element.
We will then evaluate whether, at each stage in the life cycle of the contract, we are able to recognize revenue associated with that element. To the extent that our revenue arrangements have provisions that allow our state customers to refuse acceptance of services performed, we will still be required to defer revenue recognition until such state customers accept our performance. Once this acceptance is achieved, we will immediately recognize the revenue associated with any delivered elements which differs from our current practice for arrangements entered into prior to January 1, 2011, where the revenue associated with delivered elements is recognized over the final service element of the arrangement because VSOE for the other elements does not exist. As such, we expect that the adoption of ASU No. 2009-13 will result in an overall acceleration of revenue recognition with respect to any multiple-element arrangements entered into on or after January 1, 2011.

8

Table of Contents
We began to recognize revenue and the related deferred costs associated with our Maine contract in September 2010. In Idaho, we expect to begin recognition of deferred contact costs in 2012, in a manner consistent with our anticipated recognition of revenue. Molina Medicaid Solutions’ deferred revenue totaled $36.1 million at March 31, 2011, and $10.9 million at December 31, 2010, and unamortized deferred contract costs were $37.9 million at March 31, 2011, and $28.4 million at December 31, 2010.
Recent Accounting Pronouncements
Revenue Recognition. In late 2009, the Financial Accounting Standards Board, or FASB, issued the following accounting guidance relating to revenue recognition. Effective for interim and annual reporting beginning on or after December 15, 2010, we adopted this guidance in full effective January 1, 2011.
 	•	 	ASU No. 2009-13, Revenue Recognition (ASC Topic 605) — Multiple-Deliverable Revenue Arrangements , a consensus of the FASB Emerging Issues Task Force. This guidance modifies previous requirements by requiring the use of the “best estimate of selling price” in the absence of vendor-specific objective evidence (“VSOE”) or verifiable objective evidence (“VOE”) (now referred to as “TPE” or third-party evidence) for determining the selling price of a deliverable. A vendor is now required to use its best estimate of the selling price when more objective evidence of the selling price cannot be determined. By providing an alternative for determining the selling price of deliverables, this guidance allows companies to allocate arrangement consideration in multiple deliverable arrangements in a manner that better reflects the transaction’s economics. In addition, the residual method of allocating arrangement consideration is no longer permitted under this new guidance. We have adopted this guidance effective January 1, 2011, and will apply it on a prospective basis for all new or materially modified revenue arrangements with multiple deliverables entered into on or after January 1, 2011. Because we did not enter into any new or materially modified agreements with multiple elements and fixed payments in the first quarter of 2011 that would have been impacted by this guidance, the adoption did not have a material impact on the timing or pattern of revenue recognition.	
 	 	 	 	
 	 	 	For the year ended December 31, 2010, there would have been no change in revenue recognized relating to multiple-element arrangements if we had adopted this guidance retrospectively for contracts entered into prior to January 1, 2011.	
Goodwill Impairment Testing. In December 2010, the FASB issued the following guidance which modifies goodwill impairment testing. Effective for interim and annual reporting beginning on or after December 15, 2010, we adopted this guidance in full effective January 1, 2011.
 	•	 	ASU No. 2010-28, Intangibles—Goodwill and Other (Topic 350) — When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts,  a consensus of the FASB Emerging Issues Task Force. This guidance modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that a goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that an impairment may exist. The adoption of this guidance did not impact our consolidated financial position, results of operations or cash flows.	
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, or AICPA, and the Securities and Exchange Commission, or SEC, did not have, or are not believed by management to have, a material impact on our present or future consolidated financial statements.

9

Table of Contents
3. Earnings per Share
The denominators for the computation of basic and diluted earnings per share were calculated as follows:
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	
 	 	March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(in thousands)	 	
Shares outstanding at the beginning of the period	 	 	30,309	 	 	 	25,607	 	
Weighted-average number of shares issued	 	 	83	 	 	 	39	 	
 	 	 	 	 	 	 	
Denominator for basic earnings per share	 	 	30,392	 	 	 	25,646	 	
Dilutive effect of employee stock options and stock grants (1)	 	 	446	 	 	 	191	 	
 	 	 	 	 	 	 	
Denominator for diluted earnings per share (2)	 	 	30,838	 	 	 	25,837	 	

 	 	 	
(1)	 	Options to purchase common shares are included in the calculation of diluted earnings per share when their exercise prices are below the average fair value of the common shares for each of the periods presented. For the three months ended March 31, 2011, and 2010, there were approximately 92,000 and 613,000 anti-dilutive weighted options, respectively. Restricted shares are included in the calculation of diluted earnings per share when their grant date fair values are below the average fair value of the common shares for each of the periods presented. For the three months ended March 31, 2011, and 2010, there were approximately 75,000, and 15,000 anti-dilutive weighted restricted shares, respectively.	
 	 	 	
(2)	 	Potentially dilutive shares issuable pursuant to our convertible senior notes were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the quarters ended March 31, 2011 and 2010.	
4. Share-Based Compensation
At March 31, 2011, we had employee equity incentives outstanding under two plans: (1) the 2002 Equity Incentive Plan; and (2) the 2000 Omnibus Stock and Incentive Plan (from which equity incentives are no longer awarded). On March 1, 2011, our chief executive officer, chief financial officer, and chief operating officer were awarded 100,000 shares, 75,000 shares, and 18,000 shares, respectively, of restricted stock with performance and service conditions. Each of the grants shall vest on March 1, 2012, provided that: (i) the Company’s total operating revenue for 2011 is equal to or greater than $3.7 billion, and (ii) the respective officer continues to be employed by the Company as of March 1, 2012. In the event both vesting conditions are not achieved, the equity compensation awards shall lapse. As of March 31, 2011, we expect these awards to vest in full.
Charged to general and administrative expenses, total stock-based compensation expense for the three months ended March 31, 2011 and 2010 was as follows:
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	
 	 	March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(in thousands)	 	
Restricted stock awards	 	$	3,806	 	 	$	1,638	 	
Stock options (including shares issued under our employee stock purchase plan)	 	 	258	 	 	 	498	 	
 	 	 	 	 	 	 	
Total stock-based compensation expense	 	$	4,064	 	 	$	2,136	 	
 	 	 	 	 	 	 	
As of March 31, 2011, there was $22.8 million of total unrecognized compensation expense related to unvested restricted stock awards, which we expect to recognize over a remaining weighted-average period of 2.5 years. As of March 31, 2011, there was a nominal amount of unrecognized compensation expense related to unvested stock options, which we expect to recognize in 2011.

10

Table of Contents
Unvested restricted stock and restricted stock activity for the three months ended March 31, 2011 is summarized below:
 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Weighted	 	
 	 	 	 	 	 	Average	 	
 	 	 	 	 	 	Grant Date	 	
 	 	Shares	 	 	Fair Value	 	
Unvested balance as of December 31, 2010	 	 	835,749	 	 	$	23.32	 	
Granted	 	 	455,000	 	 	 	34.50	 	
Vested	 	 	(244,321	)	 	 	24.13	 	
Forfeited	 	 	(45,687	)	 	 	25.79	 	
 	 	 	 	 	 	 	 	
Unvested balance as of March 31, 2011	 	 	1,000,741	 	 	 	28.09	 	
 	 	 	 	 	 	 	 	
The total grant date fair value of restricted shares granted during the three months ended March 31, 2011 and 2010 was $15.6 million and $9.4 million, respectively. The total fair value of restricted shares vested during the three months ended March 31, 2011 and 2010 was $8.6 million and $4.2 million, respectively. Stock option activity during the three months ended March 31, 2011 is summarized below:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	Weighted	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	Average	 	
 	 	 	 	 	 	Weighted	 	 	Aggregate	 	 	Remaining	 	
 	 	 	 	 	 	Average	 	 	Intrinsic	 	 	Contractual	 	
 	 	 	 	 	 	Exercise	 	 	Value (in	 	 	Term	 	
 	 	Shares	 	 	Price	 	 	Thousands)	 	 	(Years)	 	
Stock options outstanding as of December 31, 2010	 	 	513,614	 	 	$	30.59	 	 	 	 	 	 	 	 	 	
Exercised	 	 	(83,931	)	 	 	28.29	 	 	 	 	 	 	 	 	 	
Forfeited	 	 	(7,267	)	 	 	32.51	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Stock options outstanding as of March 31, 2011	 	 	422,416	 	 	 	31.02	 	 	$	3,995	 	 	 	4.5	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Stock options exercisable and expected to vest as of March 31, 2011	 	 	422,118	 	 	 	31.01	 	 	$	3,994	 	 	 	4.5	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Exercisable as of March 31, 2011	 	 	417,616	 	 	 	30.97	 	 	$	3,973	 	 	 	4.5	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	
5. Fair Value Measurements
Our consolidated balance sheets include the following financial instruments: cash and cash equivalents, investments, receivables, trade accounts payable, medical claims and benefits payable, long-term debt, and other liabilities. We consider the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For a comprehensive discussion of fair value measurements with regard to our current and non-current investments, see below.
The carrying amount of the convertible senior notes was $165.4 million and $164.0 million as of March 31, 2011, and December 31, 2010, respectively. Based on quoted market prices, the fair value of the convertible senior notes was approximately $213.1 million and $188.4 million as of March 31, 2011, and December 31, 2010, respectively.
To prioritize the inputs we use in measuring fair value, we apply a three-tier fair value hierarchy. These tiers include: Level 1, defined as observable inputs such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions.
As of March 31, 2011, we held certain assets that are required to be measured at fair value on a recurring basis. These included current investments in investment-grade debt securities that are designated as available-for-sale, and are reported at fair value based on market prices that are readily available (Level 1). See Note 6, “Investments,” for further information regarding fair value.
We also held investments in auction rate securities which are designated as available-for-sale, and are reported at fair value of $20.2 million (par value of $24.0 million) as of March 31, 2011.

11

Table of Contents
Our investments in auction rate securities are collateralized by student loan portfolios guaranteed by the U.S. government. We continued to earn interest on substantially all of these auction rate securities as of March 31, 2011. Due to events in the credit markets, the auction rate securities held by us experienced failed auctions beginning in the first quarter of 2008. As such, quoted prices in active markets were not readily available during the majority of 2008, 2009, and 2010, and continued to be unavailable as of March 31, 2011. To estimate the fair value of these securities, we used pricing models that included factors such as the collateral underlying the securities, the creditworthiness of the counterparty, the timing of expected future cash flows, and the expectation of the next time the security would have a successful auction. The estimated values of these securities were also compared, when possible, to valuation data with respect to similar securities held by other parties. We concluded that these estimates, given the lack of market available pricing, provided a reasonable basis for determining the fair value of the auction rate securities as of March 31, 2011. For our investments in auction rate securities, we do not intend to sell, nor is it more likely than not that we will be required to sell, these investments before recovery of their cost.
As a result of the increase in fair value of auction rate securities designated as available-for-sale, we recorded pretax unrealized gains of $0.3 million and $0.2 million to accumulated other comprehensive income (loss) for the three months ended March 31, 2011, and 2010, respectively. Any future fluctuation in fair value related to these instruments that we deem to be temporary, including any recoveries of previous write-downs, would be recorded to accumulated other comprehensive income (loss). If we determine that any future valuation adjustment was other-than-temporary, we would record a charge to earnings as appropriate.
Until July 2, 2010, we held certain auction rate securities (designated as trading securities) with an investment securities firm. In 2008, we entered into a rights agreement with this firm that (1) allowed us to exercise rights (the “Rights”) to sell the eligible auction rate securities at par value to this firm between June 30, 2010 and July 2, 2012, and (2) gave the investment securities firm the right to purchase the auction rate securities from us any time after the agreement date as long as we received the par value. On June 30, 2010, and July 1, 2010, all of the eligible auction rate securities remaining at that time were settled at par value. During 2010, the aggregate auction rate securities (designated as trading securities) settled amounted to $40.9 million par value (fair value $36.7 million). Substantially all of the difference between par value and fair value on these securities was recovered through the rights agreement. For the three months ended March 31, 2010, we recorded pretax gains of $0.5 million on the auction rate securities underlying the Rights.
We accounted for the Rights as a freestanding financial instrument and, until July 2, 2010, recorded the value of the Rights under the fair value option. For the three months ended March 31, 2010, we recorded pretax losses of $0.5 million on the Rights, attributable to the decline in the fair value of the Rights. When the remaining eligible auction rate securities were sold at par value on July 1, 2010, the value of the Rights was zero.
Our assets measured at fair value on a recurring basis at March 31, 2011, were as follows:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Total	 	 	Level 1	 	 	Level 2	 	 	Level 3	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	224,985	 	 	$	224,985	 	 	$	—	 	 	$	—	 	
Government-sponsored enterprise securities	 	 	39,372	 	 	 	39,372	 	 	 	—	 	 	 	—	 	
Municipal securities	 	 	37,906	 	 	 	37,906	 	 	 	—	 	 	 	—	 	
U.S. treasury notes	 	 	31,996	 	 	 	31,996	 	 	 	—	 	 	 	—	 	
Certificates of deposit	 	 	3,255	 	 	 	3,255	 	 	 	—	 	 	 	—	 	
Auction rate securities (available-for-sale)	 	 	20,187	 	 	 	—	 	 	 	—	 	 	 	20,187	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	357,701	 	 	$	337,514	 	 	$	—	 	 	$	20,187	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
The following table presents our assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3):
 	 	 	 	 	
 	 	(Level 3)	 	
 	 	(In thousands)	 	
Balance at December 31, 2010	 	$	20,449	 	
Total gains (realized or unrealized):	 	 	 	 	
Included in other comprehensive income	 	 	288	 	
Settlements	 	 	(550	)	
 	 	 	 	
Balance at March 31, 2011	 	$	20,187	 	

The amount of total gains for the period included in other comprehensive income attributable to the change in unrealized gains relating to assets still held at March 31, 2011	 	$	288	 	

12

Table of Contents
In 2010, we recorded a $2.8 million liability for contingent consideration related to the acquisition of our Wisconsin health plan. As of March 31, 2011, we have determined that there is no liability for contingent consideration relating to the acquisition. The liability for contingent consideration related to this acquisition was measured at fair value on a recurring basis using significant unobservable inputs (Level 3). The following table presents a roll forward of this liability for 2011:
 	 	 	 	 	
 	 	(Level 3)	 	
 	 	(In thousands)	 	
Balance at December 31, 2010	 	$	(2,800	)	
Total gains included in earnings	 	 	2,800	 	
 	 	 	 	
Balance at March 31, 2011	 	$	—	 	
 	 	 	 	
6. Investments
The following tables summarize our investments as of the dates indicated:
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	March 31, 2011	 	
 	 	 	 	 	 	Gross	 	 	Estimated	 	
 	 	 	 	 	 	Unrealized	 	 	Fair	 	
 	 	Cost	 	 	Gains	 	 	Losses	 	 	Value	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	227,099	 	 	$	176	 	 	$	2,290	 	 	$	224,985	 	
Government-sponsored enterprise securities (GSEs)	 	 	39,668	 	 	 	75	 	 	 	371	 	 	 	39,372	 	
Municipal securities (including non-current auction rate securities)	 	 	62,293	 	 	 	66	 	 	 	4,266	 	 	 	58,093	 	
U.S. treasury notes	 	 	31,982	 	 	 	102	 	 	 	88	 	 	 	31,996	 	
Certificates of deposit	 	 	3,255	 	 	 	—	 	 	 	—	 	 	 	3,255	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	364,297	 	 	$	419	 	 	$	7,015	 	 	$	357,701	 	

 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	December 31, 2010	 	
 	 	 	 	 	 	Gross	 	 	Estimated	 	
 	 	 	 	 	 	Unrealized	 	 	Fair	 	
 	 	Cost	 	 	Gains	 	 	Losses	 	 	Value	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	179,124	 	 	$	193	 	 	$	1,388	 	 	$	177,929	 	
GSEs	 	 	59,790	 	 	 	293	 	 	 	370	 	 	 	59,713	 	
Municipal securities (including non-current auction rate securities)	 	 	55,247	 	 	 	78	 	 	 	4,313	 	 	 	51,012	 	
U.S. treasury notes	 	 	23,864	 	 	 	114	 	 	 	60	 	 	 	23,918	 	
Certificates of deposit	 	 	3,252	 	 	 	—	 	 	 	—	 	 	 	3,252	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	321,277	 	 	$	678	 	 	$	6,131	 	 	$	315,824	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
The contractual maturities of our investments as of March 31, 2011 are summarized below.
 	 	 	 	 	 	 	 	 	
 	 	Amortized	 	 	Estimated	 	
 	 	Cost	 	 	Fair Value	 	
 	 	(In thousands)	 	
Due in one year or less	 	$	194,237	 	 	$	192,592	 	
Due one year through five years	 	 	146,330	 	 	 	145,064	 	
Due after five years through ten years	 	 	230	 	 	 	286	 	
Due after ten years	 	 	23,500	 	 	 	19,759	 	
 	 	 	 	 	 	 	
 	 	$	364,297	 	 	$	357,701	 	
 	 	 	 	 	 	 	
Gross realized gains and gross realized losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Total proceeds from sales and maturities of available-for-sale securities were $61.3 million and $48.5 million for the three months ended March 31, 2011 and 2010, respectively. Net realized investment gains for the three months ended March 31, 2011, and 2010 were $157,000 and $14,000, respectively.

13

Table of Contents
We monitor our investments for other-than-temporary impairment. For investments other than our municipal securities, we have determined that unrealized gains and losses at March 31, 2011, and December 31, 2010, are temporary in nature, because the change in market value for these securities has resulted from fluctuating interest rates, rather than a deterioration of the credit worthiness of the issuers. So long as we hold these securities to maturity, we are unlikely to experience gains or losses. In the event that we dispose of these securities before maturity, we expect that realized gains or losses, if any, will be immaterial.
Approximately 35% of our investment in municipal securities consists of auction rate securities. As described in Note 5, “Fair Value Measurements,” the unrealized losses on these investments were caused primarily by the illiquidity in the auction markets. Because the decline in market value is not due to the credit quality of the issuers, and because we do not intend to sell, nor is it more likely than not that we will be required to sell, these investments before recovery of their cost, we do not consider the auction rate securities that are designated as available-for-sale to be other-than-temporarily impaired at March 31, 2011.
The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of March 31, 2011.
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	In a Continuous Loss	 	 	In a Continuous Loss	 	 	 	 	
 	 	Position	 	 	Position	 	 	 	 	
 	 	for Less than 12 Months	 	 	for 12 Months or More	 	 	Total	 	
 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	
 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	
 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	143,883	 	 	$	1,962	 	 	$	11,248	 	 	$	328	 	 	$	155,131	 	 	$	2,290	 	
GSEs	 	 	9,974	 	 	 	104	 	 	 	6,331	 	 	 	267	 	 	 	16,305	 	 	 	371	 	
Municipal securities	 	 	25,274	 	 	 	330	 	 	 	24,765	 	 	 	3,936	 	 	 	50,039	 	 	 	4,266	 	
U.S. treasury notes	 	 	17,455	 	 	 	66	 	 	 	5,722	 	 	 	22	 	 	 	23,177	 	 	 	88	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	196,586	 	 	$	2,462	 	 	$	48,066	 	 	$	4,553	 	 	$	244,652	 	 	$	7,015	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of December 31, 2010.
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	In a Continuous Loss	 	 	In a Continuous Loss	 	 	 	 	
 	 	Position	 	 	Position	 	 	 	 	
 	 	for Less than 12 Months	 	 	for 12 Months or More	 	 	Total	 	
 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	 	 	Estimated	 	 	 	 	
 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	 	Fair	 	 	Unrealized	 	
 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	 	Value	 	 	Losses	 	
 	 	(In thousands)	 	
Corporate debt securities	 	$	103,225	 	 	$	1,060	 	 	$	10,490	 	 	$	328	 	 	$	113,715	 	 	$	1,388	 	
GSEs	 	 	13,014	 	 	 	71	 	 	 	7,539	 	 	 	299	 	 	 	20,553	 	 	 	370	 	
Municipal securities	 	 	18,884	 	 	 	117	 	 	 	25,271	 	 	 	4,196	 	 	 	44,155	 	 	 	4,313	 	
U.S. treasury notes	 	 	5,480	 	 	 	40	 	 	 	6,806	 	 	 	20	 	 	 	12,286	 	 	 	60	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	$	140,603	 	 	$	1,288	 	 	$	50,106	 	 	$	4,843	 	 	$	190,709	 	 	$	6,131	 	

14

Table of Contents
7. Receivables
Health Plans segment receivables consist primarily of amounts due from the various states in which we operate. Such receivables are subject to potential retroactive adjustment. Because all of our receivables are readily determinable and our creditors are in almost all instances state governments, our allowance for doubtful accounts is immaterial. Any amounts determined to be uncollectible are charged to expense when such determination is made. Accounts receivable were as follows:
 	 	 	 	 	 	 	 	 	
 	 	March 31,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Heath Plans segment:	 	 	 	 	 	 	 	 	
California	 	$	40,141	 	 	$	46,482	 	
Michigan	 	 	12,465	 	 	 	13,596	 	
Missouri	 	 	22,623	 	 	 	22,841	 	
New Mexico	 	 	10,382	 	 	 	18,310	 	
Ohio	 	 	20,904	 	 	 	21,622	 	
Washington	 	 	10,315	 	 	 	14,486	 	
Wisconsin	 	 	6,639	 	 	 	5,437	 	
Others	 	 	6,200	 	 	 	5,187	 	
 	 	 	 	 	 	 	
Total Health Plans segment	 	 	129,669	 	 	 	147,961	 	
Molina Medicaid Solutions segment	 	 	40,749	 	 	 	20,229	 	
 	 	 	 	 	 	 	
 	 	$	170,418	 	 	$	168,190	 	
 	 	 	 	 	 	 	
Our Utah health plan may be entitled to receive additional premium revenue from the state of Utah as an incentive payment for saving the state of Utah money in relation to fee-for-service Medicaid during the period 2003 through August 31, 2009. The final resolution of this matter, and the amount that may be realized by the Utah health plan, is currently uncertain and contingent upon future events. When additional information is known or agreement is reached with the state, we will recognize the resulting amount of revenue, if any, in our consolidated financial statements. No receivables for this matter have been established at March 31, 2011.
In late April of 2011, the Idaho Department of Administration delivered a letter to Molina Medicaid Solutions indicating that it wished to remit to Molina an amount approximately $5 to $6 million less than the amount of Molina’s invoices for its operation of the MMIS in that state for the period June 1, 2010 through December 31, 2010. We do not believe that the basis for the reduced payment amount is contractually sound, and have not adjusted our financial statements to reflect the requested reduction. We are currently deferring recognition of all revenue as well as all direct costs (which constitute the majority of our costs) in Idaho until the MMIS in that state receives certification from the Centers for Medicare and Medicaid Services, or CMS, which we expect to occur in 2012. Any adjustments, if necessary, to the amount of our receivable from the state of Idaho will be made as more information becomes available.
8. Restricted Investments
Pursuant to the regulations governing our health plans, we maintain statutory deposits and deposits required by state Medicaid authorities in certificates of deposit and U.S. treasury securities. Additionally, we maintain restricted investments as protection against the insolvency of capitated providers. The following table presents the balances of restricted investments by health plan, and for our insurance company:
 	 	 	 	 	 	 	 	 	
 	 	March 31,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
California	 	$	372	 	 	$	372	 	
Florida	 	 	7,981	 	 	 	4,508	 	
Insurance Company	 	 	4,682	 	 	 	4,689	 	
Michigan	 	 	1,000	 	 	 	1,000	 	
Missouri	 	 	507	 	 	 	508	 	
New Mexico	 	 	15,888	 	 	 	15,881	 	
Ohio	 	 	9,069	 	 	 	9,066	 	
Texas	 	 	3,501	 	 	 	3,501	 	
Utah	 	 	2,791	 	 	 	1,279	 	
Washington	 	 	151	 	 	 	151	 	
Wisconsin	 	 	260	 	 	 	260	 	
Other	 	 	3,105	 	 	 	885	 	
 	 	 	 	 	 	 	
 	 	$	49,307	 	 	$	42,100	 	
 	 	 	 	 	 	 	
The contractual maturities of our held-to-maturity restricted investments as of March 31, 2011 are summarized below.
 	 	 	 	 	 	 	 	 	
 	 	Amortized	 	 	Estimated	 	
 	 	Cost	 	 	Fair Value	 	
 	 	(In thousands)	 	
Due in one year or less	 	$	46,432	 	 	$	46,462	 	
Due one year through five years	 	 	2,750	 	 	 	2,743	 	
Due after five years through ten years	 	 	125	 	 	 	155	 	
 	 	 	 	 	 	 	
 	 	$	49,307	 	 	$	49,360	 	

15

Table of Contents
9. Long-Term Debt
Credit Facility
We are a party to an Amended and Restated Credit Agreement, dated as of March 9, 2005, as amended by the first amendment on October 5, 2005, the second amendment on November 6, 2006, the third amendment on May 25, 2008, the fourth amendment on April 29, 2010, and the fifth amendment on April 29, 2010, among Molina Healthcare Inc., certain lenders, and Bank of America N.A., as Administrative Agent (the “Credit Facility”) for a revolving credit line of $150 million that matures in May 2012. The Credit Facility is intended to be used for general corporate purposes. As of March 31, 2011, and December 31, 2010, there was no outstanding principal balance under the Credit Facility. However, as of March 31, 2011, our lenders had issued two letters of credit in the aggregate principal amount of $10.3 million in connection with the contract of MMS with the states of Maine and Idaho.
To the extent that in the future we incur any obligations under the Credit Facility, such obligations will be secured by a lien on substantially all of our assets and by a pledge of the capital stock of our health plan subsidiaries (with the exception of the California health plan). The Credit Facility includes usual and customary covenants for credit facilities of this type, including covenants limiting liens, mergers, asset sales, other fundamental changes, debt, acquisitions, dividends and other distributions, capital expenditures, investments, and a fixed charge coverage ratio. The Credit Facility also requires us to maintain a ratio of total consolidated debt to total consolidated EBITDA of not more than 2.75 to 1.00 at any time. At March 31, 2011, we were in compliance with all financial covenants in the Credit Facility.
The commitment fee on the total unused commitments of the lenders under the Credit Facility is 50 basis points on all levels of the pricing grid, with the pricing grid referring to our ratio of consolidated funded debt to consolidated EBITDA. The pricing for LIBOR loans and base rate loans is 200 basis points at every level of the pricing grid. Thus, the applicable margins under the Credit Facility range between 2.75% and 3.75% for LIBOR loans, and between 1.75% and 2.75% for base rate loans. The Credit Facility carves out from our indebtedness and restricted payment covenants under the Credit Facility the $187.0 million current principal amount of the convertible senior notes, although the $187.0 million indebtedness is included in the calculation of our consolidated leverage ratio. The fixed charge coverage ratio under the Credit Facility is required to be no less than 3.00x.
The fifth amendment increased the maximum consolidated leverage ratio under the Credit Facility to 3.50 to 1.0 for the first and second quarters of 2010 and through August 14, 2010 (on a pro forma basis). Effective as of August 15, 2010, the maximum consolidated leverage ratio under the Credit Facility reverted back to 2.75 to 1.0.
Convertible Senior Notes
As of March 31, 2011, $187.0 million in aggregate principal amount of our 3.75% Convertible Senior Notes due 2014 (the “Notes”) remain outstanding. The Notes rank equally in right of payment with our existing and future senior indebtedness. The Notes are convertible into cash and, under certain circumstances, shares of our common stock. The initial conversion rate is 21.3067 shares of our common stock per $1,000 principal amount of the Notes. This represents an initial conversion price of approximately $46.93 per share of our common stock. In addition, if certain corporate transactions that constitute a change of control occur prior to maturity, we will increase the conversion rate in certain circumstances.

16

Table of Contents
The proceeds from the issuance of such convertible debt instruments have been allocated between a liability component and an equity component. We have determined that the effective interest rate of the Notes is 7.5%, principally based on the seven-year U.S. treasury note rate as of the October 2007 issuance date, plus an appropriate credit spread. The resulting debt discount is being amortized over the period the Notes are expected to be outstanding, as additional non-cash interest expense. As of March 31, 2011, we expect the Notes to be outstanding until their October 1, 2014 maturity date, for a remaining amortization period of 42 months. The Notes’ if-converted value did not exceed their principal amount as of March 31, 2011. At March 31, 2011, the equity component of the Notes, net of the impact of deferred taxes, was $24.0 million. The following table provides the details of the liability amounts recorded:
 	 	 	 	 	 	 	 	 	
 	 	As of	 	 	As of	 	
 	 	March 31,	 	 	December 31,	 	
 	 	2011	 	 	2010	 	
 	 	(in thousands)	 	
Details of the liability component:	 	 	 	 	 	 	 	 	
Principal amount	 	$	187,000	 	 	$	187,000	 	
Unamortized discount	 	 	(21,646	)	 	 	(22,986	)	
 	 	 	 	 	 	 	
Net carrying amount	 	$	165,354	 	 	$	164,014	 	

 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	
 	 	March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(in thousands)	 	
Interest cost recognized for the period relating to the:	 	 	 	 	 	 	 	 	
Contractual interest coupon rate of 3.75%	 	$	1,753	 	 	$	1,753	 	
Amortization of the discount on the liability component	 	 	1,340	 	 	 	1,243	 	
 	 	 	 	 	 	 	
Total interest cost recognized	 	$	3,093	 	 	$	2,996	 	
 	 	 	 	 	 	 	
10. Stockholders’ Equity
In connection with the plans described in Note 4, “Share-Based Compensation,” we issued approximately 243,000 shares of common stock, net of shares retired to settle employees’ income taxes, for the three months ended March 31, 2011. For the three months ended March 31, 2011, the $4.2 million increase to additional paid-in capital was generated by employee stock plans transactions.
11. Segment Reporting
Our reportable segments are consistent with how we manage the business and view the markets we serve. In the second quarter of 2010, we added a segment to our internal financial reporting structure as a result of the acquisition of Molina Medicaid Solutions. We report our financial performance based on two reportable segments: Health Plans and Molina Medicaid Solutions.
We rely on an internal management reporting process that provides segment information to the operating income level for purposes of making financial decisions and allocating resources. The accounting policies of the segments are the same as those described in Note 2, “Significant Accounting Policies.” The cost of services shared between the Health Plans and Molina Medicaid Solutions segments is charged to the Health Plans segment.
Operating segment revenues and profitability for the three months ended March 31, 2011 and 2010 were as follows:
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Molina	 	 	 	 	
 	 	 	 	 	 	Medicaid	 	 	 	 	
 	 	Health Plans	 	 	Solutions	 	 	Total	 	
 	 	(In thousands)	 	
Three months ended March 31, 2011	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	$	1,081,438	 	 	$	—	 	 	$	1,081,438	 	
Service revenue	 	 	—	 	 	 	36,674	 	 	 	36,674	 	
Investment income	 	 	1,594	 	 	 	—	 	 	 	1,594	 	
 	 	 	 	 	 	 	 	 	 	
Total revenue	 	$	1,083,032	 	 	$	36,674	 	 	$	1,119,706	 	
 	 	 	 	 	 	 	 	 	 	
Operating income	 	$	29,606	 	 	$	1,694	 	 	$	31,300	 	

Three months ended March 31, 2010	 	 	 	 	 	 	 	 	 	 	 	 	
Premium revenue	 	$	965,220	 	 	$	—	 	 	$	965,220	 	
Service revenue	 	 	—	 	 	 	—	 	 	 	—	 	
Investment income	 	 	1,521	 	 	 	—	 	 	 	1,521	 	
 	 	 	 	 	 	 	 	 	 	
Total revenue	 	$	966,741	 	 	$	—	 	 	$	966,741	 	
 	 	 	 	 	 	 	 	 	 	
Operating income	 	$	20,438	 	 	$	—	 	 	$	20,438	 	

17

Table of Contents
Reconciliation to Income before Income Taxes
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	
 	 	March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Segment operating income	 	$	31,300	 	 	$	20,438	 	
Interest expense	 	 	(3,603	)	 	 	(3,357	)	
 	 	 	 	 	 	 	
Income before income taxes	 	$	27,697	 	 	$	17,081	 	
 	 	 	 	 	 	 	
Segment Assets
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Molina	 	 	 	 	
 	 	 	 	 	 	Medicaid	 	 	 	 	
 	 	Health Plans	 	 	Solutions	 	 	Total	 	
 	 	(In thousands)	 	
As of March 31, 2011	 	$	1,383,447	 	 	$	199,707	 	 	$	1,583,154	 	
 	 	 	 	 	 	 	 	 	 	
As of December 31, 2010	 	$	1,333,599	 	 	$	175,615	 	 	$	1,509,214	 	
 	 	 	 	 	 	 	 	 	 	
12. Commitments and Contingencies
Legal
The health care industry is subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues.
We are involved in various legal actions in the normal course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. These actions, when finally concluded and determined, are not likely, in our opinion, to have a material adverse effect on our business, consolidated financial position, cash flows, or results of operations.
Provider Claims
Many of our medical contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations have led certain medical providers to pursue us for additional compensation. The claims made by providers in such circumstances often involve issues of contract compliance, interpretation, payment methodology, and intent. These claims often extend to services provided by the providers over a number of years.
Various providers have contacted us seeking additional compensation for claims that we believe to have been settled. These matters, when finally concluded and determined, will not, in our opinion, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows.

18

Table of Contents
Regulatory Capital and Dividend Restrictions
Our principal operations are conducted through our health plan subsidiaries operating in California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin. Our health plans are subject to state regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent the subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. The net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us in the form of loans, advances, or cash dividends was $432.4 million at March 31, 2011, and $397.8 million at December 31, 2010. The National Association of Insurance Commissioners, or NAIC, adopted rules effective December 31, 1998, which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital (RBC) rules. Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin have adopted these rules, which may vary from state to state. California and Florida have not yet adopted NAIC risk-based capital requirements for HMOs and have not formally given notice of their intention to do so. Such requirements, if adopted by California and Florida, may increase the minimum capital required for those states.
As of March 31, 2011, our health plans had aggregate statutory capital and surplus of approximately $441.6 million compared with the required minimum aggregate statutory capital and surplus of approximately $274.1 million. All of our health plans were in compliance with the minimum capital requirements at March 31, 2011. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.
13. Related Party Transactions
We have an equity investment in a medical service provider that provides certain vision services to our members. We account for this investment under the equity method of accounting because we have an ownership interest in the investee that confers significant influence over operating and financial policies of the investee. As of both March 31, 2011 and December 31, 2010, our carrying amount for this investment totaled $4.4 million. For the three months ended March 31, 2011 and 2010, we paid $5.4 million and $4.4 million, respectively, for medical service fees to this provider.
14. Subsequent Event
On April 27, 2011, we announced that our board of directors authorized a 3-for-2 stock split of our common stock to be effected in the form of a stock dividend of one share of our stock for every two shares outstanding. The distribution of the dividend will be made on May 20, 2011.

19

Table of Contents
 	 	 	
Item 2.	 	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	
Forward Looking Statements
This quarterly report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, or Securities Act, and Section 21E of the Securities Exchange Act of 1934, or Securities Exchange Act. All statements, other than statements of historical facts, included in this quarterly report may be deemed to be forward-looking statements for purposes of the Securities Act and the Securities Exchange Act. We use the words “anticipate(s),” “believe(s),” “estimate(s),” “expect(s),” “intend(s),” “may,” “plan(s),” “project(s),” “will,” “would,” and similar expressions to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we will actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and, accordingly, you should not place undue reliance on our forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from the forward-looking statements that we make. You should read these factors and the other cautionary statements as being applicable to all related forward-looking statements wherever they appear in this quarterly report. We caution you that we do not undertake any obligation to update forward-looking statements made by us. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected, estimated, expected, or contemplated as a result of, but not limited to, risk factors related to the following:
•	 	significant budget pressures on state governments and their potential inability to maintain current rates, to implement expected rate increases, or to maintain existing benefit packages or membership eligibility thresholds or criteria;	

•	 	uncertainties regarding the impact of the Patient Protection and Affordable Care Act, including its possible repeal, judicial overturning of the individual insurance mandate, the effect of various implementing regulations, and uncertainties regarding the likely impact of other federal or state health care and insurance reform measures;	

•	 	management of our medical costs, including seasonal flu patterns and rates of utilization that are consistent with our expectations;	

•	 	the success of our efforts to retain existing government contracts and to obtain new government contracts in connection with state requests for proposals (RFPs) in both existing and new states, and our ability to grow our revenues consistent with our expectations;	

•	 	the accurate estimation of incurred but not reported medical costs across our health plans;	

•	 	risks associated with the continued growth in new Medicaid and Medicare enrollees;	

•	 	retroactive adjustments to premium revenue or accounting estimates which require adjustment based upon subsequent developments, including Medicaid pharmaceutical rebates;	

•	 	the continuation and renewal of the government contracts of both our health plans and Molina Medicaid Solutions and the terms under which such contracts are renewed;	

•	 	the timing of receipt and recognition of revenue and the amortization of expense under the state contracts of Molina Medicaid Solutions in Maine and Idaho;	

•	 	additional administrative costs and the potential payment of additional amounts to providers and/or the state by Molina Medicaid Solutions as a result of MMIS implementation issues in Idaho;	

•	 	government audits and reviews, including the audit of our Medicare plans by CMS;	

•	 	changes with respect to our provider contracts and the loss of providers;	

•	 	the establishment of a federal or state medical cost expenditure floor as a percentage of the premiums we receive, and the interpretation and implementation of medical cost expenditure floors, administrative cost and profit ceilings, and profit sharing arrangements;	

•	 	the interpretation and implementation of at-risk premium rules regarding the achievement of certain quality measures;	

•	 	approval by state regulators of dividends and distributions by our health plan subsidiaries;	

•	 	changes in funding under our contracts as a result of regulatory changes, programmatic adjustments, or other reforms;	

•	 	high dollar claims related to catastrophic illness;	

•	 	the favorable resolution of litigation or arbitration matters;	

•	 	restrictions and covenants in our credit facility;	

20

Table of Contents

•	 	the relatively small number of states in which we operate health plans;	
 	 	 	
•	 	the availability of financing to fund and capitalize our acquisitions and start-up activities and to meet our liquidity needs;	

•	 	a state’s failure to renew its federal Medicaid waiver;	

•	 	an inadvertent unauthorized disclosure of protected health information;	

•	 	changes generally affecting the managed care or Medicaid management information systems industries;	

•	 	increases in government surcharges, taxes, and assessments; and	

•	 	changes in general economic conditions, including unemployment rates.	
Investors should refer to Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010, for a discussion of certain risk factors that could materially affect our business, financial condition, cash flows, or results of operations. Given these risks and uncertainties, we can give no assurances that any results or events projected or contemplated by our forward-looking statements will in fact occur.
This document and the following discussion of our financial condition and results of operations should be read in conjunction with the accompanying consolidated financial statements and the notes to those statements appearing elsewhere in this report and the audited financial statements and Management’s Discussion and Analysis appearing in our Annual Report on Form 10-K for the year ended December 31, 2010.
Overview
Molina Healthcare, Inc. provides quality and cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals, and to assist state agencies in their administration of the Medicaid program. Our business comprises our Health Plans segment, consisting of licensed health maintenance organizations serving Medicaid populations in ten states, and our Molina Medicaid Solutions segment, which provides design, development, implementation, and business process outsourcing solutions to Medicaid agencies in an additional five states. We also have a direct delivery business that currently consists of 16 primary care community clinics in California and two primary care community clinics in Washington; additionally, we manage three county-owned primary care clinics under a contract with Fairfax County, Virginia.
Our Health Plans segment comprises health plans in California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin. These health plans served approximately 1.6 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals as of March 31, 2011. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization, or HMO.
On May 1, 2010, we acquired a health information management business which we now operate under the name, Molina Medicaid Solutions SM . Our Molina Medicaid Solutions segment provides design, development, implementation, and business process outsourcing solutions to state governments for their Medicaid Management Information Systems, or MMIS. MMIS is a core tool used to support the administration of state Medicaid and other health care entitlement programs. Molina Medicaid Solutions currently holds MMIS contracts with the states of Idaho, Louisiana, Maine, New Jersey, and West Virginia, as well as a contract to provide drug rebate administration services for the Florida Medicaid program.
We report our financial performance based on the following two reportable segments: Health Plans; and Molina Medicaid Solutions.

21

Table of Contents
First Quarter Performance Summary
The following table and narrative briefly summarizes our financial and operating performance for the three months ended March 31, 2011. Comparable metrics for the first quarter of 2010 are also shown. All ratios, with the exception of the medical care ratio and the premium tax ratio, are shown as a percentage of total revenue. The medical care ratio and the premium tax ratio are computed as a percentage of premium revenue because there are direct relationships between premium revenue earned, and the cost of health care and premium taxes.
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(Dollar amounts in thousands, except	 	
 	 	per-share data)	 	
Earnings per diluted share	 	$	0.56	 	 	$	0.41	 	
Premium revenue	 	$	1,081,438	 	 	$	965,220	 	
Service revenue	 	$	36,674	 	 	$	—	 	
Operating income	 	$	31,300	 	 	$	20,438	 	
Net income	 	$	17,388	 	 	$	10,590	 	
Total ending membership	 	 	1,647,000	 	 	 	1,482,000	 	
 	 	 	 	 	 	 	 	 	
Premium revenue	 	 	96.6	%	 	 	99.8	%	
Service revenue	 	 	3.3	 	 	 	—	 	
Investment income	 	 	0.1	 	 	 	0.2	 	
 	 	 	 	 	 	 	
Total revenue	 	 	100.0	%	 	 	100.0	%	

Medical care ratio	 	 	84.5	%	 	 	85.3	%	
General and administrative expense ratio	 	 	8.4	%	 	 	8.2	%	
Premium tax ratio	 	 	3.4	%	 	 	3.6	%	
Operating income	 	 	2.8	%	 	 	2.1	%	
Net income	 	 	1.6	%	 	 	1.1	%	
Effective tax rate	 	 	37.2	%	 	 	38.0	%	
Our first quarter of 2011 was marked by strong membership growth, flat PMPM revenue, and lower medical costs. Compared with the first quarter of 2010, earnings per share in the first quarter of 2011 were up 37%, premium revenues were up 12%, operating income was up 53%, and aggregate membership grew by 11%. Meanwhile, the aggregate medical care ratio of our health plans declined by 80 basis points. Our larger and more established health plans performed the strongest in the quarter, with each of California, Ohio, Utah, and Washington having lower medical care ratios compared with the first quarter of 2010. Our Florida and Wisconsin health plans continue to face challenges, which we are working to address. Medicare enrollment exceeded 24,000 members at March 31, 2011, and Medicare premium revenue for the quarter was $85.4 million compared with $50.3 million in the first quarter of 2010. With respect to our Molina Medicaid Solutions business, our system stabilization efforts in Idaho and Maine are taking longer and are more costly than we had anticipated. However, our profit margins in our fiscal agent contracts in New Jersey, Louisiana, and West Virginia remain stable.
We remain concerned about state budget deficits, which are not expected to improve during the remainder of 2011. Accordingly, the rate environment for our health plans remains uncertain. However, our Missouri health plan has received notification that it will receive a blended rate increase of approximately 5% effective July 1, 2011. On May 5, 2011, we learned that our responsive bid in Arizona in connection with the re-procurement of the ALTCS program (Acute + Long Term Care Services) was not successful. The Company is in the process of reviewing and evaluating the bid scores and may file a protest as warranted. We continue to await the results of Molina Medicaid Solutions’ responsive bid in Louisiana to retain its MMIS contract in that state.
Composition of Revenue and Membership
Health Plans Segment
Our Health Plans segment derives its revenue, in the form of premiums, chiefly from Medicaid contracts with the states in which our health plans operate. Premium revenue is fixed in advance of the periods covered and, except as described in “Critical Accounting Policies” below, is not generally subject to significant accounting estimates. For the three months ended March 31, 2011, we received approximately 94% of our premium revenue as a fixed per-member per-month, or PMPM, amount, pursuant to our Medicaid contracts with state agencies, our Medicare contracts with the Centers for Medicare and Medicaid Services, or CMS, and our contracts with other managed care organizations for which we operate as a subcontractor. These premium revenues are recognized in the month that members are entitled to receive health care services. The state Medicaid programs and the federal Medicare program periodically adjust premium rates.
For the three months ended March 31, 2011, we received approximately 6% of our premium revenue in the form of “birth income” — a one-time payment for the delivery of a child — from the Medicaid programs in all of our state health plans except New Mexico. Such payments are recognized as revenue in the month the birth occurs.
The amount of the premiums paid to us may vary substantially between states and among various government programs. PMPM premiums for the Children’s Health Insurance Program, or CHIP, members are generally among our lowest, with rates as low as approximately $75 PMPM in California. Premium revenues for Medicaid members are generally higher. Among the Temporary Assistance for Needy Families, or TANF, Medicaid population — the Medicaid group that includes mostly mothers and children — PMPM premiums range between approximately $100 in California to $230 in Missouri. Among our Medicaid Aged, Blind or Disabled, or ABD, membership, PMPM premiums range from approximately $320 in Utah to $1,000 in Ohio. Contributing to the variability in Medicaid rates among the states is the practice of some states to exclude certain benefits from the managed care contract (most often pharmacy and catastrophic case benefits) and retain responsibility for those benefits at the state level. Medicare membership generates the highest PMPM premiums, at nearly $1,200 PMPM.

22

Table of Contents
The following table sets forth the approximate total number of members by state health plan as of the dates indicated:
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	March 31,	 	 	December 31,	 	 	March 31,	 	
 	 	2011	 	 	2010	 	 	2010	 	
Total Ending Membership by Health Plan:	 	 	 	 	 	 	 	 	 	 	 	 	
California	 	 	347,000	 	 	 	344,000	 	 	 	353,000	 	
Florida	 	 	66,000	 	 	 	61,000	 	 	 	52,000	 	
Michigan	 	 	225,000	 	 	 	227,000	 	 	 	226,000	 	
Missouri	 	 	82,000	 	 	 	81,000	 	 	 	78,000	 	
New Mexico	 	 	90,000	 	 	 	91,000	 	 	 	92,000	 	
Ohio	 	 	248,000	 	 	 	245,000	 	 	 	228,000	 	
Texas	 	 	128,000	 	 	 	94,000	 	 	 	40,000	 	
Utah	 	 	80,000	 	 	 	79,000	 	 	 	75,000	 	
Washington	 	 	341,000	 	 	 	355,000	 	 	 	338,000	 	
Wisconsin(1)	 	 	40,000	 	 	 	36,000	 	 	 	—	 	
 	 	 	 	 	 	 	 	 	 	
Total	 	 	1,647,000	 	 	 	1,613,000	 	 	 	1,482,000	 	
 	 	 	 	 	 	 	 	 	 	
Total Ending Membership by State for our Medicare Advantage Plans(1):	 	 	 	 	 	 	 	 	 	 	 	 	
California	 	 	5,300	 	 	 	4,900	 	 	 	2,700	 	
Florida	 	 	600	 	 	 	500	 	 	 	300	 	
Michigan	 	 	6,700	 	 	 	6,300	 	 	 	4,200	 	
New Mexico	 	 	700	 	 	 	600	 	 	 	600	 	
Ohio	 	 	400	 	 	 	—	 	 	 	—	 	
Texas	 	 	600	 	 	 	700	 	 	 	500	 	
Utah	 	 	6,700	 	 	 	8,900	 	 	 	7,100	 	
Washington	 	 	3,300	 	 	 	2,600	 	 	 	1,600	 	
 	 	 	 	 	 	 	 	 	 	
Total	 	 	24,300	 	 	 	24,500	 	 	 	17,000	 	
 	 	 	 	 	 	 	 	 	 	
Total Ending Membership by State for our Aged, Blind or Disabled Population:	 	 	 	 	 	 	 	 	 	 	 	 	
California	 	 	14,100	 	 	 	13,900	 	 	 	13,400	 	
Florida	 	 	10,300	 	 	 	10,000	 	 	 	8,900	 	
Michigan	 	 	32,000	 	 	 	31,700	 	 	 	32,700	 	
New Mexico	 	 	5,600	 	 	 	5,700	 	 	 	5,800	 	
Ohio	 	 	28,200	 	 	 	28,200	 	 	 	26,700	 	
Texas	 	 	51,200	 	 	 	19,000	 	 	 	18,100	 	
Utah	 	 	8,200	 	 	 	8,000	 	 	 	7,900	 	
Washington	 	 	4,300	 	 	 	4,000	 	 	 	3,500	 	
Wisconsin(1)	 	 	1,700	 	 	 	1,700	 	 	 	—	 	
 	 	 	 	 	 	 	 	 	 	
Total	 	 	155,600	 	 	 	122,200	 	 	 	117,000	 	

(1)	 	We acquired the Wisconsin health plan on September 1, 2010. As of March 31, 2011, the Wisconsin health plan had approximately 2,400 Medicare Advantage members that are ceded 100% under a reinsurance contract with a third party; these members are not included in the membership tables herein.	
Molina Medicaid Solutions Segment
Molina Medicaid Solutions’ MMIS contracts extend over a number of years, and cover the life of the MMIS from inception through at least the first five years of its operation. The contracts are subject to extension by the exercise of an option, and also by renewal of the base contract. The contracts have a life cycle beginning with the design, development, and implementation of the MMIS and continuing through the operation of the system. Payment during the design, development, and implementation phase of the contract, or the DDI phase, is generally based upon the attainment of specific milestones in systems development as agreed upon ahead of time by the parties. Payment during the operations phase typically takes the form of either a flat monthly fee or payment for specific measures of capacity or activity, such as the number of claims processed, or the number of Medicaid beneficiaries served by the MMIS. Contracts may also call for the adjustment of amounts paid if certain activity measures exceed or fall below certain thresholds. In some circumstances, revenue recognition may be delayed for long periods while we await formal customer acceptance of our products and/or services. In those circumstances, recognition of a portion of our costs may also be deferred.
Under our contracts in Louisiana, New Jersey, and West Virginia, we provide primarily business process outsourcing and technology outsourcing services, because the development of the MMIS solution has been completed. Under these contracts, we recognize outsourcing service revenue on a straight-line basis over the remaining term of the contract. In Maine, we completed the DDI phase of our contract effective September 1, 2010. In Idaho, we expect to complete the DDI phase of our contract during 2011. We began revenue and cost recognition for our Maine contract in September 2010, and expect to begin revenue and cost recognition for our Idaho contract in 2012.

23

Table of Contents
Additionally, Molina Medicaid Solutions provides pharmacy rebate administration services under a contract with the state of Florida.
Composition of Expenses
Health Plans Segment
Operating expenses for the Health Plans segment include expenses related to the provision of medical care services, G&A expenses, and premium tax expenses. Our results of operations are impacted by our ability to effectively manage expenses related to medical care services and to accurately estimate medical costs incurred. Expenses related to medical care services are captured in the following four categories:
 	•	 	Fee-for-service — Expenses paid for specific encounters or episodes of care according to a fee schedule or other basis established by the state or by contract with the provider.	

 	•	 	Capitation — Expenses for PMPM payments to the provider without regard to the frequency, extent, or nature of the medical services actually furnished.	

 	•	 	Pharmacy — Expenses for all drug, injectible, and immunization costs paid primarily through our pharmacy benefit manager.	

 	•	 	Other — Expenses for medically related administrative costs of approximately $24.4 million, and $19.6 million, for the three months ended March 31, 2011, and 2010, respectively, including certain provider incentive costs, reinsurance, costs to operate our medical clinics, and other medical expenses.	
Our medical care costs include amounts that have been paid by us through the reporting date as well as estimated liabilities for medical care costs incurred but not paid by us as of the reporting date. See “Critical Accounting Policies” below for a comprehensive discussion of how we estimate such liabilities.
Molina Medicaid Solutions Segment
Cost of service revenue consists primarily of the costs incurred to provide business process outsourcing and technology outsourcing services under our contracts in Louisiana, Maine, New Jersey, West Virginia, and Florida, as well as certain selling, general and administrative expenses. Additionally, certain indirect costs incurred under our contracts in Maine (prior to exiting the DDI phase of that contract in September, 2010) and Idaho are also expensed to cost of services.
In some circumstances we may defer recognition of incremental direct costs (such as direct labor, hardware, and software) associated with a contract if revenue recognition is also deferred. Such deferred contract costs are amortized on a straight-line basis over the remaining original contract term, consistent with the revenue recognition period. We began to recognize deferred costs for our Maine contract in September 2010, at the same time we began to recognize revenue associated with that contract. In Idaho, we expect to begin recognition of deferred contact costs in 2012, in a manner consistent with our anticipated recognition of revenue.

24

Table of Contents
Results of Operations
Three Months Ended March 31, 2011 Compared with the Three Months Ended March 31, 2010
Health Plans Segment
Premium Revenue
Premium revenue grew 12% in the three months ended March 31, 2011 compared with the three months ended March 31, 2010, due to a membership increase of 11%. Consolidated premium revenue increased by approximately 1% on a PMPM basis. Medicare enrollment exceeded 24,000 members at March 31, 2011, and Medicare premium revenue was $85.4 million for the three months ended March 31, 2011, compared with $50.3 million for the three months ended March 31, 2010.
Medical Care Costs
The following table provides the details of consolidated medical care costs for the periods indicated (dollars in thousands except PMPM amounts):
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended March 31,	 	
 	 	2011	 	 	2010	 	
 	 	 	 	 	 	 	 	 	 	% of	 	 	 	 	 	 	 	 	 	 	% of	 	
 	 	Amount	 	 	PMPM	 	 	Total	 	 	Amount	 	 	PMPM	 	 	Total	 	
Fee-for-service	 	$	655,884	 	 	$	133.78	 	 	 	71.8	%	 	$	566,879	 	 	$	128.06	 	 	 	68.9	%	
Capitation	 	 	128,682	 	 	 	26.25	 	 	 	14.1	 	 	 	137,132	 	 	 	30.98	 	 	 	16.7	 	
Pharmacy	 	 	91,576	 	 	 	18.68	 	 	 	10.0	 	 	 	90,071	 	 	 	20.35	 	 	 	10.9	 	
Other	 	 	37,390	 	 	 	7.63	 	 	 	4.1	 	 	 	28,734	 	 	 	6.48	 	 	 	3.5	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Total	 	$	913,532	 	 	$	186.34	 	 	 	100.0	%	 	$	822,816	 	 	$	185.87	 	 	 	100.0	%	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
The medical care ratio decreased to 84.5% in the three months ended March 31, 2011, compared with 85.3% for the three months ended March 31, 2010. Total medical care costs increased less than 1% PMPM, while medical care costs for our Medicaid membership decreased by approximately 2% PMPM.
 	•	 	Pharmacy costs (adjusted for the state’s retention of the pharmacy benefit in Ohio effective February 1, 2010) increased approximately 5% PMPM.	

 	•	 	Capitation costs decreased approximately 15% PMPM, primarily due to the transition of members in Michigan and Washington into fee-for-service networks.	

 	•	 	Fee-for-service costs increased approximately 4% PMPM, partially due to the transition of members from capitated provider networks into fee-for-service networks. Fee-for-service and capitation costs combined increased less than 1% PMPM.	

 	•	 	Hospital admissions per thousand members per year decreased approximately 7%.	

 	•	 	Pharmacy utilization was essentially flat, with the increase in costs being driven by higher costs per prescription.	
The medical care ratio of the California health plan decreased to 84.3% in the three months ended March 31, 2011, from 86.8% in the three months ended March 31, 2010, as higher premium revenue PMPM more than offset an increase of approximately 27% in pharmacy costs and an increase of approximately 5% in fee-for-service costs.
The medical care ratio of the Florida health plan increased to 96.6% in the three months ended March 31, 2011, from 88.7% in the three months ended March 31, 2010, primarily due to higher fee-for-service and capitation costs, which more than offset lower pharmacy costs. We have undertaken a number of measures — focused on both utilization and unit cost reductions — to improve the profitability of the Florida health plan. The Florida health plan’s medical care ratio decreased from 100.2% in the fourth quarter of 2010.
The medical care ratio of the Michigan health plan increased to 81.2% in the three months ended March 31, 2011, from 80.8% in the three months ended March 31, 2010, as higher physician and outpatient facility fee-for-service costs and higher pharmacy costs more than offset lower capitation costs.

25

Table of Contents
The medical care ratio of the Missouri health plan increased to 93.6% in the three months ended March 31, 2011, from 83.5% in the three months ended March 31, 2010, due to higher fee-for-service costs.
The medical care ratio of the New Mexico health plan increased to 82.8% in the three months ended March 31, 2011, from 77.4% in the three months ended March 31, 2010, as lower fee-for-service costs failed to offset the impact of a premium rate decrease of approximately 8.5% PMPM.
The medical care ratio of the Ohio health plan decreased to 74.6% in the three months ended March 31, 2011, from 79.1% in the three months ended March 31, 2010, due to an increase in Medicaid premium PMPM of approximately 4.5% effective January 1, 2011, and flat fee-for-service costs.
The medical care ratio of the Texas health plan increased to 91.1% in the three months ended March 31, 2011, from 82.5% in the three months ended March 31, 2010. Effective February 1, 2011, we added approximately 30,000 ABD Medicaid members in the Dallas-Fort Worth area, and effective September 1, 2010, we added approximately 54,000 members state-wide who are covered under CHIP.
The medical care ratio of the Utah health plan decreased to 79.3% in the three months ended March 31, 2011, from 105.0% in the three months ended March 31, 2010, primarily due to reduced fee-for-service costs in the outpatient facility and physician categories and an increase in Medicaid premium PMPM of approximately 7% effective July 1, 2010. Lower fee-for-service costs were the result of both lower unit costs and lower utilization.
The medical care ratio of the Washington health plan decreased to 86.6% in the first quarter of 2011 from 90.3% in the three months ended March 31, 2010. Lower capitation costs more than offset higher fee-for-service and higher pharmacy costs. Pharmacy costs for the Washington health plan’s Medicaid members grew approximately 22% PMPM.
The medical care ratio of the Wisconsin health plan (acquired September 1, 2010) was 118.1% in the three months ended March 31, 2011. The Wisconsin health plan recorded a premium deficiency reserve of $3.35 million in the first quarter of 2011. Absent that premium deficiency reserve, the Wisconsin health plan’s medical care ratio would have been approximately 98% for the three months ended March 31, 2011.
Health Plans Segment Operating Data
The following table summarizes member months, premium revenue, medical care costs, medical care ratio, and premium taxes by health plan for the periods indicated (PMPM amounts are in whole dollars; member months and other dollar amounts are in thousands):
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Three Months Ended March 31, 2011	 	
 	 	Member	 	 	Premium Revenue	 	 	Medical Care Costs	 	 	Medical	 	 	Premium Tax	 	
 	 	Months(1)	 	 	Total	 	 	PMPM	 	 	Total	 	 	PMPM	 	 	Care Ratio	 	 	Expense	 	
California	 	 	1,041	 	 	$	134,976	 	 	$	129.63	 	 	$	113,737	 	 	$	109.24	 	 	 	84.3	%	 	$	1,902	 	
Florida	 	 	192	 	 	 	49,222	 	 	 	256.63	 	 	 	47,568	 	 	 	248.01	 	 	 	96.6	 	 	 	17	 	
Michigan	 	 	678	 	 	 	164,760	 	 	 	243.06	 	 	 	133,728	 	 	 	197.28	 	 	 	81.2	 	 	 	9,846	 	
Missouri	 	 	245	 	 	 	55,166	 	 	 	225.33	 	 	 	51,608	 	 	 	210.79	 	 	 	93.6	 	 	 	—	 	
New Mexico	 	 	271	 	 	 	84,606	 	 	 	311.93	 	 	 	70,038	 	 	 	258.21	 	 	 	82.8	 	 	 	1,965	 	
Ohio	 	 	737	 	 	 	230,340	 	 	 	312.68	 	 	 	171,752	 	 	 	233.15	 	 	 	74.6	 	 	 	17,775	 	
Texas	 	 	349	 	 	 	80,811	 	 	 	231.49	 	 	 	73,615	 	 	 	210.88	 	 	 	91.1	 	 	 	1,340	 	
Utah	 	 	236	 	 	 	67,935	 	 	 	287.77	 	 	 	53,839	 	 	 	228.06	 	 	 	79.3	 	 	 	—	 	
Washington	 	 	1,034	 	 	 	195,272	 	 	 	188.81	 	 	 	169,116	 	 	 	163.52	 	 	 	86.6	 	 	 	3,642	 	
Wisconsin(2)	 	 	120	 	 	 	16,417	 	 	 	137.25	 	 	 	19,380	 	 	 	162.02	 	 	 	118.1	 	 	 	—	 	
Other(3)	 	 	—	 	 	 	1,933	 	 	 	—	 	 	 	9,151	 	 	 	—	 	 	 	—	 	 	 	63	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	4,903	 	 	$	1,081,438	 	 	$	220.58	 	 	$	913,532	 	 	$	186.34	 	 	 	84.5	%	 	$	36,550	 	

26

Table of Contents
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	 	 	 	Three Months Ended March 31, 2010	 	
 	 	Member	 	 	Premium Revenue	 	 	Medical Care Costs	 	 	Medical	 	 	Premium Tax	 	
 	 	Months(1)	 	 	Total	 	 	PMPM	 	 	Total	 	 	PMPM	 	 	Care Ratio	 	 	Expense	 	
California	 	 	1,062	 	 	$	123,910	 	 	$	116.67	 	 	$	107,561	 	 	$	101.28	 	 	 	86.8	%	 	$	1,628	 	
Florida	 	 	154	 	 	 	39,088	 	 	 	253.45	 	 	 	34,687	 	 	 	224.91	 	 	 	88.7	 	 	 	6	 	
Michigan	 	 	675	 	 	 	155,345	 	 	 	230.13	 	 	 	125,449	 	 	 	185.85	 	 	 	80.8	 	 	 	9,939	 	
Missouri	 	 	234	 	 	 	52,143	 	 	 	223.01	 	 	 	43,516	 	 	 	186.11	 	 	 	83.5	 	 	 	—	 	
New Mexico	 	 	280	 	 	 	95,598	 	 	 	341.02	 	 	 	74,015	 	 	 	264.03	 	 	 	77.4	 	 	 	2,004	 	
Ohio	 	 	673	 	 	 	218,363	 	 	 	324.35	 	 	 	172,625	 	 	 	256.41	 	 	 	79.1	 	 	 	17,005	 	
Texas	 	 	121	 	 	 	39,200	 	 	 	324.08	 	 	 	32,331	 	 	 	267.29	 	 	 	82.5	 	 	 	681	 	
Utah	 	 	221	 	 	 	58,540	 	 	 	265.51	 	 	 	61,460	 	 	 	278.76	 	 	 	105.0	 	 	 	—	 	
Washington	 	 	1,007	 	 	 	181,054	 	 	 	179.84	 	 	 	163,510	 	 	 	162.42	 	 	 	90.3	 	 	 	3,262	 	
Wisconsin(2)	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	 	 	—	 	
Other(3)	 	 	—	 	 	 	1,979	 	 	 	—	 	 	 	7,662	 	 	 	—	 	 	 	—	 	 	 	21	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	 	4,427	 	 	$	965,220	 	 	$	218.04	 	 	$	822,816	 	 	$	185.87	 	 	 	85.3	%	 	$	34,546	 	

 	 	 	
(1)	 	A member month is defined as the aggregate of each month’s ending membership for the period presented.	
 	 	 	
(2)	 	We acquired the Wisconsin health plan on September 1, 2010.	
 	 	 	
(3)	 	“Other” medical care costs also include medically related administrative costs at the parent company.	
Days in Medical Claims and Benefits Payable
The days in medical claims and benefits payable were as follows:
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	March 31,	 	 	Dec. 31,	 	 	March 31,	 	
 	 	2011	 	 	2010	 	 	2010	 	
Days in claims payable — fee-for-service only	 	41 days	 	 	42 days	 	 	44 days	 	
Number of claims in inventory at end of period	 	 	185,300	 	 	 	143,600	 	 	 	153,700	 	
Billed charges of claims in inventory at end of period (in thousands)	 	$	250,600	 	 	$	218,900	 	 	$	194,000	 	
Molina Medicaid Solutions Segment
Performance of the Molina Medicaid Solutions segment for the three months ended March 31, 2011 was as follows:
 	 	 	 	 	
 	 	(In thousands)	 	
Service revenue before amortization	 	$	38,860	 	
Less: amortization of contract backlog recorded as contra-service revenue	 	 	(2,186	)	
 	 	 	 	
Service revenue	 	 	36,674	 	
Cost of service revenue	 	 	31,221	 	
General and administrative costs	 	 	2,477	 	
Amortization of customer relationship intangibles recorded as amortization	 	 	1,282	 	
 	 	 	 	
Operating income	 	$	1,694	 	
 	 	 	 	
Consolidated Expenses
General and Administrative Expenses
General and administrative, or G&A, expenses, were $94.4 million, or 8.4% of total revenue, for the three months ended March 31, 2011 compared with $78.9 million, or 8.2% of total revenue, for the three months ended March 31, 2010.
Premium Tax Expense
Premium tax expense decreased to 3.4% of premium revenue in the three months ended March 31, 2011 from 3.6% in the three months ended March 31, 2010.

27

Table of Contents
Depreciation and Amortization
Depreciation and amortization related to our Health Plans segment is all recorded in “Depreciation and Amortization” in the consolidated statements of income. Depreciation and amortization related to our Molina Medicaid Solutions segment is recorded within three different headings in the consolidated statements of income as follows:
 	•	 	Amortization of purchased intangibles relating to customer relationships is reported as amortization within the heading “Depreciation and Amortization;”	

 	•	 	Amortization of purchased intangibles relating to contract backlog is recorded as a reduction of “Service Revenue;” and	

 	•	 	Depreciation is recorded within the heading “Cost of Service Revenue.”	
The following table presents all depreciation and amortization recorded in our consolidated statements of income, regardless of whether the item appears as depreciation and amortization, a reduction of revenue, or as cost of service revenue, and reconciles that amount to the consolidated statements of cash flows.
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended March 31,	 	
 	 	2011	 	 	2010	 	
 	 	 	 	 	 	% of Total	 	 	 	 	 	 	% of Total	 	
 	 	Amount	 	 	Revenue	 	 	Amount	 	 	Revenue	 	
 	 	(In thousands)	 	
Depreciation	 	$	7,401	 	 	 	0.7	%	 	$	6,412	 	 	 	0.7	%	
Amortization of intangible assets	 	 	5,266	 	 	 	0.4	 	 	 	3,649	 	 	 	0.3	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Depreciation and amortization reported in the consolidated statements of income	 	 	12,667	 	 	 	1.1	 	 	 	10,061	 	 	 	1.0	 	
Amortization recorded as reduction of service revenue	 	 	2,186	 	 	 	0.2	 	 	 	—	 	 	 	—	 	
Depreciation recorded as cost of service revenue	 	 	3,241	 	 	 	0.3	 	 	 	—	 	 	 	—	 	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Depreciation and amortization reported in the consolidated statements of cash flows	 	$	18,094	 	 	 	1.6	%	 	$	10,061	 	 	 	1.0	%	
 	 	 	 	 	 	 	 	 	 	 	 	 	
Interest Expense
Interest expense increased to $3.6 million for the three months ended March 31, 2011, from $3.4 million for the three months ended March 31, 2010. Interest expense includes non-cash interest expense relating to our convertible senior notes, which totaled $1.3 million and $1.2 million for the three months ended March 31, 2011, and 2010, respectively.
Income Taxes
Income tax expense was recorded at an effective rate of 37.2% for the three months ended March 31, 2011 compared with 38.0% for the three months ended March 31, 2010. The lower rate in 2011 was primarily due to lower state income taxes.
Liquidity and Capital Resources
We manage our cash, investments, and capital structure to meet the short- and long-term obligations of our business while maintaining liquidity and financial flexibility. We forecast, analyze, and monitor our cash flows to enable prudent investment management and financing within the confines of our financial strategy.

28

Table of Contents
Our regulated subsidiaries generate significant cash flows from premium revenue and investment income. Such cash flows are our primary source of liquidity. Thus, any future decline in our premium revenue or our profitability may have a negative impact on our liquidity. We generally receive premium revenue in advance of the payment of claims for the related health care services. A majority of the assets held by our regulated subsidiaries are in the form of cash, cash equivalents, and investments. After considering expected cash flows from operating activities, we generally invest cash of regulated subsidiaries that exceeds our expected short-term obligations in longer term, investment-grade, marketable debt securities to improve our overall investment return. These investments are made pursuant to board approved investment policies which conform to applicable state laws and regulations. Our investment policies are designed to provide liquidity, preserve capital, and maximize total return on invested assets, all in a manner consistent with state requirements that prescribe the types of instruments in which our subsidiaries may invest. These investment policies require that our investments have final maturities of five years or less (excluding auction rate securities and variable rate securities, for which interest rates are periodically reset) and that the average maturity be two years or less. Professional portfolio managers operating under documented guidelines manage our investments. As of March 31, 2011, a substantial portion of our cash was invested in a portfolio of highly liquid money market securities, and our investments consisted solely of investment-grade debt securities. All of our investments are classified as current assets, except for our investments in auction rate securities, which are classified as non-current assets. Our restricted investments are invested principally in certificates of deposit and U.S. treasury securities.
Investment income increased slightly to $1.6 million for the three months ended March 31, 2011, compared with $1.5 million for the three months ended March 31, 2010.
Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. We have the ability to hold our restricted investments until maturity and, as a result, we would not expect to incur significant losses due to a sudden change in market interest rates. Declines in interest rates over time will reduce our investment income.
Cash in excess of the capital needs of our regulated health plans is generally paid to our unregulated parent company in the form of dividends, when and as permitted by applicable regulations, for general corporate use.
Cash provided by operating activities for the three months ended March 31, 2011 was $84.1 million compared with $26.2 million used in operating activities for the three months ended March 31, 2010, an increase of $110.3 million. The change is primarily attributable to the advance premium payment made in March 2011 by the state of Ohio to our Ohio health plan in the amount of $72.7 million. Deferred revenue, which was a use of operating cash totaling $90.7 million in three months ended March 31, 2010, was a source of operating cash totaling $84.2 million in the three months ended March 31, 2011. The change in deferred revenue was offset by changes in other current assets and liabilities.
Reconciliation of Non-GAAP(1) to GAAP Financial Measures
EBITDA(2)
 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended	 	
 	 	March 31,	 	
 	 	2011	 	 	2010	 	
 	 	(In thousands)	 	
Operating income	 	$	31,300	 	 	$	20,438	 	
Add back:	 	 	 	 	 	 	 	 	
Depreciation and amortization reported in the consolidated statements of cash flows	 	 	18,094	 	 	 	10,061	 	
 	 	 	 	 	 	 	
EBITDA	 	$	49,394	 	 	$	30,499	 	

 	 	 	
(1)	 	GAAP stands for U.S. generally accepted accounting principles.	
 	 	 	
(2)	 	We calculate EBITDA consistently on a quarterly and annual basis by adding back depreciation and amortization to operating income. Operating income includes investment income. EBITDA is not prepared in conformity with GAAP because it excludes depreciation and amortization, as well as interest expense, and the provision for income taxes. This non-GAAP financial measure should not be considered as an alternative to the GAAP measures of net income, operating income, operating margin, or cash provided by operating activities, nor should EBITDA be considered in isolation from these GAAP measures of operating performance. Management uses EBITDA as a supplemental metric in evaluating our financial performance, in evaluating financing and business development decisions, and in forecasting and analyzing future periods. For these reasons, management believes that EBITDA is a useful supplemental measure to investors in evaluating our performance and the performance of other companies in our industry.	

29

Table of Contents
Capital Resources
At March 31, 2011, the parent company — Molina Healthcare, Inc. — held cash and investments of approximately $25.6 million, compared with approximately $65.1 million of cash and investments at December 31, 2010. This decline was primarily due to capital contributions and/or advances to our Florida, Texas, and Wisconsin health plans in the first quarter of 2011.
On a consolidated basis, at March 31, 2011, we had working capital of $399.6 million compared with $392.4 million at December 31, 2010. At March 31, 2011, we had cash and investments of $870.8 million, compared with approximately $813.8 million of cash and investments at December 31, 2010.
We believe that our cash and credit resources and internally generated funds will be sufficient to support our operations, regulatory requirements, and capital expenditures for at least the next 12 months.
Credit Facility
We are a party to an Amended and Restated Credit Agreement, dated as of March 9, 2005, as amended by the first amendment on October 5, 2005, the second amendment on November 6, 2006, the third amendment on May 25, 2008, the fourth amendment on April 29, 2010, and the fifth amendment on April 29, 2010, among Molina Healthcare Inc., certain lenders, and Bank of America N.A., as Administrative Agent (the “Credit Facility”) for a revolving credit line of $150 million that matures in May 2012. The Credit Facility is intended to be used for general corporate purposes. As of March 31, 2011, and December 31, 2010, there was no outstanding principal debt balance under the Credit Facility. However, as of March 31, 2011, our lenders had issued two letters of credit in the aggregate principal amount of $10.3 million in connection with the contract of MMS with the states of Maine and Idaho.
To the extent that in the future we incur any obligations under the Credit Facility, such obligations will be secured by a lien on substantially all of our assets and by a pledge of the capital stock of our health plan subsidiaries (with the exception of the California health plan). The Credit Facility includes usual and customary covenants for credit facilities of this type, including covenants limiting liens, mergers, asset sales, other fundamental changes, debt, acquisitions, dividends and other distributions, capital expenditures, investments, and a fixed charge coverage ratio. The Credit Facility also requires us to maintain a ratio of total consolidated debt to total consolidated EBITDA of not more than 2.75 to 1.00 at any time. At March 31, 2011, we were in compliance with all financial covenants in the Credit Facility.
The commitment fee on the total unused commitments of the lenders under the Credit Facility is 50 basis points on all levels of the pricing grid, with the pricing grid referring to our ratio of consolidated funded debt to consolidated EBITDA. The pricing for LIBOR loans and base rate loans is 200 basis points at every level of the pricing grid. Thus, the applicable margins under the Credit Facility range between 2.75% and 3.75% for LIBOR loans, and between 1.75% and 2.75% for base rate loans. The Credit Facility carves out from our indebtedness and restricted payment covenants under the Credit Facility the $187.0 million current principal amount of the convertible senior notes, although the $187.0 million indebtedness is included in the calculation of our consolidated leverage ratio. The fixed charge coverage ratio under the Credit Facility is required to be no less than 3.00x.
The fifth amendment increased the maximum consolidated leverage ratio under the Credit Facility to 3.50 to 1.0 for the first and second quarters of 2010 and through August 14, 2010 (on a pro forma basis). Effective as of August 15, 2010, the maximum consolidated leverage ratio under the Credit Facility reverted back to 2.75 to 1.0.
Shelf Registration Statement
In December 2008, we filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission covering the issuance of up to $300 million of our securities, including common stock, warrants, or debt securities, and up to 250,000 shares of outstanding common stock that may be sold from time to time by the Molina Siblings Trust as a selling stockholder. We may publicly offer securities from time to time at prices and terms to be determined at the time of the offering. As a result of the offering described below, we may now offer up to $182.5 million of our securities from time to time under the shelf registration statement.
In August 2010, we sold 4,350,000 shares of common stock covered by this registration statement. The public offering price for this sale was $25.65 per share, net of the underwriting discount. Our proceeds from the sales totaled approximately $111.1 million, net of the issuance costs. We used the proceeds from these sales to repay the Credit Facility and for general corporate purposes. Also in August 2010, the Molina Siblings Trust, as a selling stockholder, sold 250,000 shares of outstanding common stock covered by this registration statement.

30

Table of Contents
Convertible Senior Notes
As of March 31, 2011, $187.0 million in aggregate principal amount of our 3.75% Convertible Senior Notes due 2014 (the “Notes”) remain outstanding. The Notes rank equally in right of payment with our existing and future senior indebtedness. The Notes are convertible into cash and, under certain circumstances, shares of our common stock. The initial conversion rate is 21.3067 shares of our common stock per $1,000 principal amount of the Notes. This represents an initial conversion price of approximately $46.93 per share of our common stock. In addition, if certain corporate transactions that constitute a change of control occur prior to maturity, we will increase the conversion rate in certain circumstances.
Regulatory Capital and Dividend Restrictions
Our principal operations are conducted through our health plan subsidiaries operating in California, Florida, Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin. The health plans are subject to state laws that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and may restrict the timing, payment, and amount of dividends and other distributions that may be paid to Molina Healthcare, Inc. as the sole stockholder of each of our health plans. To the extent the subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. The net assets in these subsidiaries, after intercompany eliminations, which may not be transferable to us in the form of loans, advances, or cash dividends totaled $432.4 million at March 31, 2011, and $397.8 million at December 31, 2010.
The National Association of Insurance Commissioners, or NAIC, adopted rules effective December 31, 1998, which, if adopted by a particular state, set minimum capitalization requirements for health plans and other insurance entities bearing risk for health care coverage. The requirements take the form of risk-based capital, or RBC, rules. These rules, which vary slightly from state to state, have been adopted in Michigan, Missouri, New Mexico, Ohio, Texas, Utah, Washington, and Wisconsin. California and Florida have not adopted RBC rules and have not given notice of any intention to do so. The RBC rules, if adopted by California and Florida, may increase the minimum capital required by those states.
At March 31, 2011, our health plans had aggregate statutory capital and surplus of approximately $441.6 million, compared to the required minimum aggregate statutory capital and surplus of approximately $274.1 million. All of our health plans were in compliance with the minimum capital requirements at March 31, 2011. We have the ability and commitment to provide additional working capital to each of our health plans when necessary to ensure that capital and surplus continue to meet regulatory requirements. Barring any change in regulatory requirements, we believe that we will continue to be in compliance with these requirements through 2011.
Critical Accounting Policies
When we prepare our consolidated financial statements, we use estimates and assumptions that may affect reported amounts and disclosures. Actual results could differ from these estimates. Our most significant accounting policies relate to:
 	•	 	The determination of the amount of revenue to be recognized under certain contracts that place revenue at risk dependent upon the achievement of certain quality or administrative measurements, or the expenditure of certain percentages of revenue on defined expenses, or requirements that we return a certain portion of our profits to state governments;	

 	•	 	The deferral of revenue and costs associated with contracts held by our Molina Medicaid Solutions segment; and	

 	•	 	The determination of medical claims and benefits payable.	

31

Table of Contents
Revenue Recognition — Health Plans Segment
Certain components of premium revenue of our Health Plans segment are subject to accounting estimates, and are therefore subject to retroactive revision. Chief among these are:
 	•	 	Florida Health Plan Medical Cost Floor (Minimum) for Behavioral Health: A portion of premium revenue paid to our Florida health plan by the state of Florida may be refunded to the state if certain minimum amounts are not spent on defined behavioral health care costs. At March 31, 2011, we had not recorded any liability under the terms of this contract provision. If the state of Florida disagrees with our interpretation of the existing contract terms, an adjustment to the amounts owed may be required. Any changes to the terms of this provision, including revisions to the definitions of premium revenue or behavioral health care costs, the period of time over which performance is measured or the manner of its measurement, or the percentages used in the calculations, may affect the profitability of our Florida health plan.	

 	•	 	New Mexico Health Plan Medical Cost Floors (Minimums) and Administrative Cost and Profit Ceilings (Maximums):  A portion of premium revenue paid to our New Mexico health plan by the state of New Mexico may be refunded to the state if certain minimum amounts are not spent on defined medical care costs, or if administrative costs or profit (as defined) exceed certain amounts. Our contract with the state of New Mexico requires that we spend a minimum percentage of premium revenue on certain explicitly defined medical care costs (the medical cost floor). Our contract is for a three-year period, and the medical cost floor is based on premiums and medical care costs over the entire contract period. Effective July 1, 2008, our New Mexico health plan entered into a new three year contract that, in addition to retaining the medical cost floor, added certain limits on the amount our New Mexico health plan can: (a) expend on administrative costs; and (b) retain as profit. At March 31, 2011, we had recorded a liability of $7.0 million under the terms of these contract provisions. If the state of New Mexico disagrees with our interpretation of the existing contract terms, an adjustment to the amounts owed may be required. Any changes to the terms of these provisions, including revisions to the definitions of premium revenue, medical care costs, administrative costs or profit, the period of time over which performance is measured or the manner of its measurement, or the percentages used in the calculations, may affect the profitability of our New Mexico health plan.	

 	•	 	New Mexico Health Plan At-Risk Premium Revenue: Under our contract with the state of New Mexico, up to 1% of our New Mexico health plan’s revenue may be refundable to the state if certain performance measures are not met. These performance measures are generally linked to various quality of care and administrative measures dictated by the state. For the state fiscal year ending June 30, 2011 (the only contract year currently open for determination of at-risk premium revenue), our New Mexico health plan has received $1.9 million in at-risk revenue as of March 31, 2011. To date, we have recognized $0.9 million of that amount as revenue, and recorded a liability of approximately $1.0 million as of March 31, 2011, for the remainder. If the state of New Mexico disagrees with our estimation of our compliance with the at-risk premium requirements, an adjustment to the amounts owed may be required.	

 	•	 	Ohio Health Plan At-Risk Premium Revenue: Under our contract with the state of Ohio, up to 1% of our Ohio health plan’s revenue may be refundable to the state if certain performance measures are not met. Effective February 1, 2010 an additional 0.25% of the Ohio health plan’s revenue became refundable if certain pharmacy specific performance measures were not met. These performance measures are generally linked to various quality-of-care measures dictated by the state. The state of Ohio’s fiscal year ends June 30, and open contract years typically include the current state fiscal year and the immediately preceding state fiscal year (two state fiscal years in total). For the two open state fiscal years ending June 30, 2011, our Ohio health plan has received $8.5 million in at-risk revenue as of March 31, 2011. To date, we have recognized $4.7 million of that amount as revenue and recorded a liability of approximately $3.8 million as of March 31, 2011, for the remainder. If the state of Ohio disagrees with our estimation of our compliance with the at-risk premium requirements, an adjustment to the amounts owed may be required. For example, during the third quarter of 2010, we reversed the recognition of approximately $3.3 million of at-risk revenue of which $1.9 million and $1.4 million were initially recognized in 2010, and 2009, respectively.	

 	•	 	Utah Health Plan Premium Revenue: Our Utah health plan may be entitled to receive additional premium revenue from the state of Utah as an incentive payment for saving the state of Utah money in relation to fee-for-service Medicaid during the period 2003 through August 31, 2009. In prior years, we estimated amounts we believed were recoverable under our savings sharing agreement with the state of Utah based on available information and our interpretation of our contract with the state. The state may not agree with our interpretation or our application of the contract language, and it may also not agree with the manner in which we have processed and analyzed our member claims and encounter records. Thus, the ultimate amount of savings sharing revenue that we realize from prior years may be subject to negotiation with the state. During 2007, as a result of an ongoing disagreement with the state of Utah, we wrote off the entire receivable, totaling $4.7 million.	

32

Table of Contents
 	 	 	Our Utah health plan continues to assert its claim to the amounts believed to be due under the savings share agreement. On April 19, 2011, the Director of the Utah Department of Health issued a Final Agency Order in an administrative proceeding initiated by our Utah health plan relating to the proper interpretation of the savings sharing language in the parties’ state fiscal year 2006 contract. Pursuant to that Order, the Department adopted the administrative law judge’s finding that the Utah health plan’s interpretation of the contract was correct and that the savings sharing amount due to the Utah health plan should be calculated under the health plan’s interpretation. The parties are in the process of calculating the net amounts due to the health plan for fiscal year 2006 and for all other years covered by the savings sharing language.	

 	 	 	The final resolution of this matter, and the amount that may be realized by the Utah health plan, is currently uncertain and contingent upon future events. When additional information is known or agreement is reached with the state regarding the appropriate savings sharing payment amount, we will recognize that amount of savings sharing revenue, if any, in our financial statements. No receivables for saving sharing revenue have been established at March 31, 2011.	

 	•	 	Texas Health Plan Profit Sharing: Under our contract with the state of Texas there is a profit-sharing agreement, where we pay a rebate to the state of Texas if our Texas health plan generates pretax income, as defined in the contract, above a certain specified percentage, as determined in accordance with a tiered rebate schedule. We are limited in the amount of administrative costs that we may deduct in calculating the rebate, if any. As of March 31, 2011, we had an aggregate liability of approximately $0.1 million accrued pursuant to our profit-sharing agreement with the state of Texas for the 2010 and 2011 contract years (ending August 31 st  of each year). Because the final settlement calculations include a claims run-out period of nearly one year, an adjustment to the amounts owed may be required.	

 	•	 	Texas Health Plan At-Risk Premium Revenue: Under our contract with the state of Texas, up to 1% of our Texas health plan’s revenue may be refundable to the state if certain performance measures are not met. These performance measures are generally linked to various quality-of-care measures established by the state. The time period for the assessment of these performance measures had previously followed the state’s fiscal year, but effective January 1, 2011, it follows the calendar year. As of March 31, 2011, our Texas health plan has received $0.6 million in at-risk revenue, none of which has been recognized as revenue as of March 31, 2011. If the state of Texas disagrees with our estimation of our compliance with the at-risk premium requirements, an adjustment to the amounts owed may be required.	

 	•	 	Medicare Premium Revenue: Based on member encounter data that we submit to CMS, our Medicare revenue is subject to retroactive adjustment for both member risk scores and member pharmacy cost experience for up to two years after the original year of service. This adjustment takes into account the acuity of each member’s medical needs relative to what was anticipated when premiums were originally set for that member. In the event that a member requires less acute medical care than was anticipated by the original premium amount, CMS may recover premium from us. In the event that a member requires more acute medical care than was anticipated by the original premium amount, CMS may pay us additional retroactive premium. A similar retroactive reconciliation is undertaken by CMS for our Medicare members’ pharmacy utilization. That analysis is similar to the process for the adjustment of member risk scores, but is further complicated by member pharmacy cost sharing provisions attached to the Medicare pharmacy benefit that do not apply to the services measured by the member risk adjustment process. We estimate the amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members’ heath care utilization patterns and CMS practices. Based on our knowledge of member health care utilization patterns, there is no liability related to the potential recoupment of Medicare premium revenue at March 31, 2011. To the extent that the premium revenue ultimately received from CMS differs from recorded amounts, we will adjust reported Medicare revenue.	

33

Table of Contents
Deferral of Service Revenue and Cost of Service Revenue — Molina Medicaid Solutions Segment
The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of three elements of service. The first of these is the design, development and implementation, or DDI, of a Medicaid Management Information System, or MMIS. The second element, following completion of the DDI element, is the operation of the MMIS under a business process outsourcing, or BPO arrangement. While providing BPO services, we also provide the state with the third contracted element — training and IT support and hosting services (training and support).
Because they include these three elements of service, our Molina Medicaid Solutions contracts are multiple-element arrangements. The following discussion applies to our contracts with multiple elements entered into prior to January 1, 2011, before our prospective adoption of  ASU No. 2009-13, Revenue Recognition (ASC Topic 605) — Multiple-Deliverable Revenue Arrangements .
For those contracts entered into prior to January 1, 2011, we have no vendor specific objective evidence, or VSOE, of fair value for any of the individual elements in these contracts, and at no point in the contract will we have VSOE for the undelivered elements in the contract. We lack VSOE of the fair value of the individual elements of our Molina Medicaid Solutions contracts for the following reasons:
 	•	 	Each contract calls for the provision of its own specific set of products and services, which vary significantly between contracts; and	

 	•	 	The nature of the MMIS installed varies significantly between our older contracts (proprietary mainframe systems) and our newer contracts (commercial off-the-shelf technology solutions).	
The absence of VSOE within the context of a multiple element arrangement requires us to delay recognition of any revenue for an MMIS contract until completion of the DDI phase of the contract. Although the length of the DDI phase for any MMIS contract can vary considerably, the DDI phase typically takes about two years to complete. As a general principle, revenue recognition will therefore commence at the completion of the DDI phase, and all revenue will be recognized over the period that BPO services and training and support services are provided. Consistent with the deferral of revenue, recognition of all direct costs (such as direct labor, hardware, and software) associated with the DDI phase of our contracts is deferred until the commencement of revenue recognition. Deferred costs are recognized on a straight-line basis over the period of revenue recognition.
Provisions specific to each contract may, however, lead us to modify this general principle. In those circumstances, the right of the state to refuse acceptance of services, as well as the related obligation to compensate us, may require us to delay recognition of all or part of our revenue until that contingency (the right of the state to refuse acceptance) has been removed. In those circumstances we defer recognition of any revenue at risk (whether DDI, BPO services, or training and support services) until the contingency had been removed. In these circumstances, we would also defer recognition of incremental direct costs (such as direct labor, hardware, and software) associated with the contract (whether DDI, BPO services, or training and support services) on which revenue recognition is being deferred. Such deferred contract costs are recognized on a straight-line basis over the period of revenue recognition.
For all new or materially modified revenue arrangements with multiple elements entered into on or after January 1, 2011, which we expect will consist of contracts entered into by our Molina Medicaid Solutions segment, we will apply the guidance contained in ASU No. 2009-13. For these arrangements, we will allocate total arrangement consideration to the elements of the arrangement, which are expected to be DDI, BPO, and training and support, because this is consistent with the current elements included in our Molina Medicaid Solutions contracts. The arrangement allocation will be performed using the relative selling-price method. When determining the selling price of each element, we will first attempt to use VSOE if available. If VSOE is not available, we will attempt to use third-party evidence, or TPE, of vendors selling similar services to similarly situated customers on a standalone basis, if available. If neither VSOE nor TPE are available, we will use our best estimate of the selling price for each element.
We will then evaluate whether, at each stage in the life cycle of the contract, we are able to recognize revenue associated with that element. To the extent that our revenue arrangements have provisions that allow our state customers to refuse acceptance of services performed, we will still be required to defer revenue recognition until such state customers accept our performance. Once this acceptance is achieved, we will immediately recognize the revenue associated with any delivered elements which differs from our current practice for arrangements entered into prior to January 1, 2011, where the revenue associated with delivered elements is recognized over the final service element of the arrangement because VSOE for the other elements does not exist. As such, we expect that the adoption of ASU No. 2009-13 will result in an overall acceleration of revenue recognition with respect to any multiple-element arrangements entered into on or after January 1, 2011.
We began to recognize revenue and related deferred costs associated with our Maine contract in September 2010. In Idaho, we expect to begin recognition of deferred contact costs in 2012, in a manner consistent with our anticipated recognition of revenue. Molina Medicaid Solutions’ deferred revenue totaled $36.1 million at March 31, 2011, and $10.9 million at December 31, 2010, and unamortized deferred contract costs were $37.9 million at March 31, 2011, and $28.4 million at December 31, 2010.
The recoverability of deferred contract costs associated with a particular contract is analyzed on a periodic basis using the undiscounted estimated cash flows of the whole contract over its remaining contract term. If such undiscounted cash flows are insufficient to recover the long-lived assets and deferred contract costs, the long-lived asset is written down by the amount of the cash flow deficiency. If a cash flow deficiency remains after reducing the balance of the long-lived asset to zero, any remaining deferred contract costs are evaluated for impairment. Any such impairment recognized would equal the amount by which the carrying value of the long-lived assets and deferred contract costs exceed the fair value of those assets.

34

Table of Contents
Medical Claims and Benefits Payable — Health Plans Segment
The following table provides the details of our medical claims and benefits payable as of the dates indicated:
 	 	 	 	 	 	 	 	 	
 	 	March 31, 2011	 	 	Dec. 31, 2010	 	
 	 	(In thousands)	 	
Fee-for-service claims incurred but not paid (IBNP)	 	$	273,378	 	 	$	275,259	 	
Capitation payable	 	 	43,738	 	 	 	49,598	 	
Pharmacy	 	 	16,953	 	 	 	14,649	 	
Other	 	 	17,313	 	 	 	14,850	 	
 	 	 	 	 	 	 	
 	 	$	351,382	 	 	$	354,356	 	
 	 	 	 	 	 	 	
The determination of our liability for claims and medical benefits payable is particularly important to the determination of our financial position and results of operations in any given period. Such determination of our liability requires the application of a significant degree of judgment by our management.
As a result, the determination of our liability for claims and medical benefits payable is subject to an inherent degree of uncertainty. Our medical care costs include amounts that have been paid by us through the reporting date, as well as estimated liabilities for medical care costs incurred but not paid by us as of the reporting date. Such medical care cost liabilities include, among other items, unpaid fee-for-service claims, capitation payments owed providers, unpaid pharmacy invoices, and various medically related administrative costs that have been incurred but not paid. We use judgment to determine the appropriate assumptions for determining the required estimates.
The most important element in estimating our medical care costs is our estimate for fee-for-service claims which have been incurred but not paid by us. These fee-for-service costs that have been incurred but have not been paid at the reporting date are collectively referred to as medical costs that are “Incurred But Not Paid,” or IBNP. Our IBNP, as reported on our balance sheet, represents our best estimate of the total amount of claims we will ultimately pay with respect to claims that we have incurred as of the balance sheet date. We estimate our IBNP monthly using actuarial methods based on a number of factors. As indicated in the table above, our estimated IBNP liability represented $273.4 million of our total medical claims and benefits payable of $351.4 million as of March 31, 2011. Excluding amounts that we anticipate paying on behalf of a capitated provider in Ohio (which we will subsequently withhold from that provider’s monthly capitation payment), our IBNP liability at March 31, 2011, was $267.4 million.
The factors we consider when estimating our IBNP include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, health care service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims. Our assessment of these factors is then translated into an estimate of our IBNP liability at the relevant measuring point through the calculation of a base estimate of IBNP, a further reserve for adverse claims development, and an estimate of the administrative costs of settling all claims incurred through the reporting date. The base estimate of IBNP is derived through application of claims payment completion factors and trended PMPM cost estimates.
For the fifth month of service prior to the reporting date and earlier, we estimate our outstanding claims liability based on actual claims paid, adjusted for estimated completion factors. Completion factors seek to measure the cumulative percentage of claims expense that will have been paid for a given month of service as of the reporting date, based on historical payment patterns.

35

Table of Contents
The following table reflects the change in our estimate of claims liability as of March 31, 2011 that would have resulted had we changed our completion factors for the fifth through the twelfth months preceding March 31, 2011 by the percentages indicated. A reduction in the completion factor results in an increase in medical claims liabilities. Dollar amounts are in thousands.
 	 	 	 	 	
(Decrease) Increase in	 	Increase (Decrease) in	 	
Estimated	 	Medical Claims and	 	
Completion Factors	 	Benefits Payable	 	
(6)%	 	$	83,261	 	
(4)%	 	 	55,507	 	
(2)%	 	 	27,754	 	
2%	 	 	(27,754	)	
4%	 	 	(55,507	)	
6%	 	 	(83,261	)	
For the four months of service immediately prior to the reporting date, actual claims paid are not a reliable measure of our ultimate liability, given the inherent delay between the patient/physician encounter and the actual submission of a claim for payment. For these months of service, we estimate our claims liability based on trended PMPM cost estimates. These estimates are designed to reflect recent trends in payments and expense, utilization patterns, authorized services, and other relevant factors. The following table reflects the change in our estimate of claims liability as of March 31, 2011 that would have resulted had we altered our trend factors by the percentages indicated. An increase in the PMPM costs results in an increase in medical claims liabilities. Dollar amounts are in thousands.
 	 	 	 	 	
(Decrease) Increase in	 	(Decrease) Increase in	 	
Trended Per member Per Month	 	Medical Claims and	 	
Cost Estimates	 	Benefits Payable	 	
(6)%	 	$	(67,651	)	
(4)%	 	 	(45,101	)	
(2)%	 	 	(22,550	)	
2%	 	 	22,550	 	
4%	 	 	45,101	 	
6%	 	 	67,651	 	
The following per-share amounts are based on a combined federal and state statutory tax rate of 37.5%, and 30.8 million diluted shares outstanding for the three months ended March 31, 2011. Assuming a hypothetical 1% change in completion factors from those used in our calculation of IBNP at March 31, 2011, net income for the three months ended March 31, 2011 would increase or decrease by approximately $8.7 million, or $0.28 per diluted share. Assuming a hypothetical 1% change in PMPM cost estimates from those used in our calculation of IBNP at March 31, 2011, net income for the three months ended March 31, 2011 would increase or decrease by approximately $7.0 million, or $0.23 per diluted share. The corresponding figures for a 5% change in completion factors and PMPM cost estimates would be $43.4 million, or $1.41 per diluted share, and $35.2 million, or $1.14 per diluted share, respectively.
It is important to note that any change in the estimate of either completion factors or trended PMPM costs would usually be accompanied by a change in the estimate of the other component, and that a change in one component would almost always compound rather than offset the resulting distortion to net income. When completion factors are  overestimated , trended PMPM costs tend to be  underestimated . Both circumstances will create an overstatement of net income. Likewise, when completion factors are  underestimated , trended PMPM costs tend to be  overestimated , creating an understatement of net income. In other words, errors in estimates involving both completion factors and trended PMPM costs will usually act to drive estimates of claims liabilities and medical care costs in the same direction. If completion factors were overestimated by 1%, resulting in an overstatement of net income by approximately $8.7 million, it is likely that trended PMPM costs would be underestimated, resulting in an additional overstatement of net income.
After we have established our base IBNP reserve through the application of completion factors and trended PMPM cost estimates, we then compute an additional liability, once again using actuarial techniques, to account for adverse developments in our claims payments which the base actuarial model is not intended to and does not account for. We refer to this additional liability as the

36

Table of Contents
provision for adverse claims development. The provision for adverse claims development is a component of our overall determination of the adequacy of our IBNP. It is intended to capture the potential inadequacy of our IBNP estimate as a result of our inability to adequately assess the impact of factors such as changes in the speed of claims receipt and payment, the relative magnitude or severity of claims, known outbreaks of disease such as influenza, our entry into new geographical markets, our provision of services to new populations such as the aged, blind or disabled (ABD), changes to state-controlled fee schedules upon which a large proportion of our provider payments are based, modifications and upgrades to our claims processing systems and practices, and increasing medical costs. Because of the complexity of our business, the number of states in which we operate, and the need to account for different health care benefit packages among those states, we make an overall assessment of IBNP after considering the base actuarial model reserves and the provision for adverse claims development. We also include in our IBNP liability an estimate of the administrative costs of settling all claims incurred through the reporting date. The development of IBNP is a continuous process that we monitor and refine on a monthly basis as additional claims payment information becomes available. As additional information becomes known to us, we adjust our actuarial model accordingly to establish IBNP.
On a monthly basis, we review and update our estimated IBNP and the methods used to determine that liability. Any adjustments, if appropriate, are reflected in the period known. While we believe our current estimates are adequate, we have in the past been required to increase significantly our claims reserves for periods previously reported, and may be required to do so again in the future. Any significant increases to prior period claims reserves would materially decrease reported earnings for the period in which the adjustment is made.
In our judgment, the estimates for completion factors will likely prove to be more accurate than trended PMPM cost estimates because estimated completion factors are subject to fewer variables in their determination. Specifically, completion factors are developed over long periods of time, and are most likely to be affected by changes in claims receipt and payment experience and by provider billing practices. Trended PMPM cost estimates, while affected by the same factors, will also be influenced by health care service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, outbreaks of disease or increased incidence of illness, provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims. As discussed above, however, errors in estimates involving trended PMPM costs will almost always be accompanied by errors in estimates involving completion factors, and vice versa. In such circumstances, errors in estimation involving both completion factors and trended PMPM costs will act to drive estimates of claims liabilities (and therefore medical care costs) in the same direction.
Assuming that base reserves have been adequately set, we believe that amounts ultimately paid out should generally be between 8% and 10% less than the liability recorded at the end of the period as a result of the inclusion in that liability of the allowance for adverse claims development and the accrued cost of settling those claims. However, there can be no assurance that amounts ultimately paid out will not be higher or lower than this 8% to 10% range, as shown by our results for the year ended December 31, 2010, when the amounts ultimately paid out were less than the amount of the reserves we had established as of the beginning of that year by 15.7%.
As shown in greater detail in the table below, the amounts ultimately paid out on our prior period liabilities in fiscal years 2010 and through March 31, 2011, were less than what we had expected when we had established our reserves. While the specific reasons for the overestimation of our liabilities were different in each of the periods presented, in general the overestimations were tied to our assessment of specific circumstances at our individual health plans which were unique to those reporting periods.
We recognized a benefit from prior period claims development in the amount of $44.4 million for the three months ended March 31, 2011 (see table below). This amount represents our estimate as of March 31, 2011 of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2010 exceeded the amount that will ultimately be paid out in satisfaction of that liability. The overestimation of claims liability at December 31, 2010 was due primarily to the following factors:
 	•	 	We overestimated the impact of an increase in pending high dollar claims at our Ohio health plan.	

 	•	 	We underestimated the lower cost associated with changes to provider fee schedules (primarily for outpatient facility costs) in New Mexico effective November 1, 2010.	

37

Table of Contents
The following developments partially offset the overestimation of our claims liability at December 31, 2010:
 	•	 	In Missouri, delays in claims processing late in the fourth quarter of 2010 led us to underestimate the size of our claims liability at December 31, 2010.	

 	•	 	We underestimated the costs associated with our assumption of risk for a new population in Texas (rural CHIP members) effective September 1, 2010.	
We recognized a benefit from prior period claims development in the amount of $38.5 million, and $49.4 million for the three months ended March 31, 2010, and the year ended December 31, 2010, respectively (see table below). This was primarily caused by the overestimation of our liability for claims and medical benefits payable at December 31, 2009. The overestimation of claims liability at December 31, 2009 was the result of the following factors:
 	•	 	In New Mexico, we underestimated the degree to which cuts to the Medicaid fees schedule would reduce our liability as of December 31, 2009.	

 	•	 	In California, we underestimated the extent to which various network restructuring, provider contracting, and medical management initiatives had reduced our medical care costs during the second half of 2009, thereby resulting in a lower liability at December 31, 2009.	
In estimating our claims liability at March 31, 2011, we adjusted our base calculation to take account of the following factors that we believe are reasonably likely to change our final claims liability amount:
 	•	 	The assumption of risk for a new population by our Texas health plan (Dallas-Fort Worth area ABD members) effective February 1, 2011.	

 	•	 	The transition of certain members by our Washington and Michigan health plans from full-risk capitated provider arrangements to fee-for-service providers effective December 31, 2010. This change had the effect of transferring back to the Company risk that had previously been assumed by capitated medical providers.	

 	•	 	A substantial decline in claims inventory at our Florida and New Mexico health plans.	

 	•	 	A substantial increase in claims inventory at our Michigan, Missouri, and Texas health plans.	

 	•	 	Our liability for an unknown number of maternity related claims that were mistakenly paid on our behalf by the state of Michigan.	
The use of a consistent methodology in estimating our liability for claims and medical benefits payable minimizes the degree to which the underestimation or overestimation of that liability at the close of one period may affect consolidated results of operations in subsequent periods. Facts and circumstances unique to the estimation process at any single date, however, may still lead to a material impact on consolidated results of operations in subsequent periods. Any absence of adverse claims development (as well as the expensing through general and administrative expense of the costs to settle claims held at the start of the period) will lead to the recognition of a benefit from prior period claims development in the period subsequent to the date of the original estimate. In 2010 and through March 31, 2011, the absence of adverse development of the liability for claims and medical benefits payable at the close of the previous period resulted in the recognition of substantial favorable prior period development. In both periods, however, the recognition of a benefit from prior period claims development did not have a material impact on our consolidated results of operations because the amount of benefit recognized in each year was roughly consistent with that recognized in the previous year.

38

Table of Contents
The following table presents the components of the change in our medical claims and benefits payable for the periods presented. The negative amounts displayed for “ Components of medical care costs related to:  Prior years” represent the amount by which our original estimate of claims and benefits payable at the beginning of the period exceeded the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported.
 	 	 	 	 	 	 	 	 	 	 	 	 	
 	 	Three Months Ended March 31,	 	 	Year Ended	 	
 	 	2011	 	 	2010	 	 	Dec. 31, 2010	 	
 	 	(Dollars in thousands, except	 	
 	 	per-member amounts)	 	
Balances at beginning of year	 	$	354,356	 	 	$	315,316	 	 	$	315,316	 	
Balance of acquired subsidiary	 	 	—	 	 	 	—	 	 	 	3,228	 	
Components of medical care costs related to:	 	 	 	 	 	 	 	 	 	 	 	 	
Current year	 	 	957,909	 	 	 	861,271	 	 	 	3,420,235	 	
Prior years	 	 	(44,377	)	 	 	(38,455	)	 	 	(49,378	)	
 	 	 	 	 	 	 	 	 	 	
Total medical care costs	 	 	913,532	 	 	 	822,816	 	 	 	3,370,857	 	
 	 	 	 	 	 	 	 	 	 	
Payments for medical care costs related to:	 	 	 	 	 	 	 	 	 	 	 	 	
Current year	 	 	646,428	 	 	 	581,389	 	 	 	3,085,388	 	
Prior years	 	 	270,078	 	 	 	230,970	 	 	 	249,657	 	
 	 	 	 	 	 	 	 	 	 	
Total paid	 	 	916,506	 	 	 	812,359	 	 	 	3,335,045	 	
 	 	 	 	 	 	 	 	 	 	
Balances at end of year	 	$	351,382	 	 	$	325,773	 	 	$	354,356	 	

Benefit from prior years as a percentage of:	 	 	 	 	 	 	 	 	 	 	 	 	
Balance at beginning of year	 	 	12.5	%	 	 	12.1	%	 	 	15.7	%	
Premium revenue	 	 	4.1	%	 	 	4.0	%	 	 	1.2	%	
Medical care costs	 	 	4.9	%	 	 	4.7	%	 	 	1.5	%	
Claims Data:	 	 	 	 	 	 	 	 	 	 	 	 	
Days in claims payable, fee for service only	 	 	41	 	 	 	44	 	 	 	42	 	
Number of members at end of period	 	 	1,647,000	 	 	 	1,482,000	 	 	 	1,613,000	 	
Fee-for-service claims processing and inventory information:	 	 	 	 	 	 	 	 	 	 	 	 	
Number of claims in inventory at end of period	 	 	185,300	 	 	 	153,700	 	 	 	143,600	 	
Billed charges of claims in inventory at end of period	 	$	250,600	 	 	$	194,000	 	 	$	218,900	 	
Claims in inventory per member at end of period	 	 	0.11	 	 	 	0.10	 	 	 	0.09	 	
Billed charges of claims in inventory per member at end of period	 	$	152.16	 	 	$	130.90	 	 	$	135.71	 	
Number of claims received during the period	 	 	4,342,200	 	 	 	3,493,300	 	 	 	14,554,800	 	
Billed charges of claims received during the period	 	$	3,386,600	 	 	$	2,760,500	 	 	$	11,686,100	 	
Inflation
We use various strategies to mitigate the negative effects of health care cost inflation. Specifically, our health plans try to control medical and hospital costs through contracts with independent providers of health care services. Through these contracted providers, our health plans emphasize preventive health care and appropriate use of specialty and hospital services. There can be no assurance, however, that our strategies to mitigate health care cost inflation will be successful. Competitive pressures, new health care and pharmaceutical product introductions, demands from health care providers and customers, applicable regulations, or other factors may affect our ability to control health care costs.
Compliance Costs
Our health plans are regulated by both state and federal government agencies. Regulation of managed care products and health care services is an evolving area of law that varies from jurisdiction to jurisdiction. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Changes in applicable laws and rules occur frequently. Compliance with such laws and rules may lead to additional costs related to the implementation of additional systems, procedures, and programs that we have not yet identified.

39

Table of Contents
 	 	 	
Item 3.	 	Quantitative and Qualitative Disclosures About Market Risk.	
Concentrations of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. We invest a substantial portion of our cash in the PFM Funds Prime Series — Institutional Class, and the PFM Funds Government Series. These funds represent a portfolio of highly liquid money market securities that are managed by PFM Asset Management LLC (PFM), a Virginia business trust registered as an open-end management investment fund. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. No investment that is in a loss position can be sold by our managers without our prior approval. Our investments consist solely of investment grade debt securities with a maximum maturity of five years or less and an average duration of two years or less. Restricted investments are invested principally in certificates of deposit and U.S. treasury securities. Concentration of credit risk with respect to accounts receivable is limited due to payors consisting principally of the governments of each state in which our Health Plans segment and our Molina Medicaid Solutions segment operate.
 	 	 	
Item 4.	 	Controls and Procedures	
Evaluation of Disclosure Controls and Procedures: Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has concluded, based upon its evaluation as of the end of the period covered by this report, that the Company’s “disclosure controls and procedures” (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.
Changes in Internal Control Over Financial Reporting: There has been no change in our internal control over financial reporting during the three months ended March 31, 2011 that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

40

Table of Contents
PART II — OTHER INFORMATION
 	 	 	
Item 1.	 	Legal Proceedings	
The health care industry is subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines, exclusion from participating in publicly-funded programs, and the repayment of previously billed and collected revenues.
We are involved in various legal actions in the normal course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. Based upon the evaluation of information currently available, we believe that these actions, when finally concluded and determined, are not likely to have a material adverse effect on our business, financial condition, cash flows, or results of operations.
 	 	 	
Item 1A.	 	Risk Factors	
Certain risk factors may have a material adverse effect on our business, financial condition, cash flows, or results of operations, and you should carefully consider them. There has been no material change to the risk factors identified in Part 1, Item 1A — Risk Factors, in our Annual Report on Form 10-K for the year ended December 31, 2010 as filed with the SEC on March 8, 2011.
 	 	 	
Item 6.	 	Exhibits	

Exhibit No.	 	Title	
 	31.1	 	 	Certification of Chief Executive Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	31.2	 	 	Certification of Chief Financial Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	32.1	 	 	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 	 	 	 	 	
 	32.2	 	 	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	

41

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 	 	 	 	 	
 	MOLINA HEALTHCARE, INC.
(Registrant)
 	 	
Dated: May 9, 2011 	/s/ JOSEPH M. MOLINA, M.D.  	 	
 	Joseph M. Molina, M.D. 	 	
 	Chairman of the Board, Chief Executive Officer
and President (Principal Executive Officer)  	 	
 	 	 	 	 	
Dated: May 9, 2011 	/s/ JOHN C. MOLINA, J.D.  	 	
 	John C. Molina, J.D. 	 	
 	Chief Financial Officer and Treasurer
(Principal Financial Officer)  	 	

42

Table of Contents
EXHIBIT INDEX
 	 	 	 	 	
Exhibit No.	 	Title	
 	31.1	 	 	Certification of Chief Executive Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	31.2	 	 	Certification of Chief Financial Officer pursuant to Rules 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended.	
 	 	 	 	 	
 	32.1	 	 	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	
 	 	 	 	 	
 	32.2	 	 	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	

43

EXHIBIT 31.1
CERTIFICATION PURSUANT TO
RULES 13a-14(a)/15d-14(a)
UNDER THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED
I, Joseph M. Molina, M.D., certify that:
1. I have reviewed the report on Form 10-Q for the period ended March 31, 2011 of Molina Healthcare, Inc.;
2. Based on my knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
3. Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), and internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended), for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period for which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in the report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the report based on such evaluation; and
(d) Disclosed in the report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 	 	 	 	 	
Dated: May 9, 2011 	/s/ Joseph M. Molina, M.D.  	 	
 	Joseph M. Molina, M.D. 	 	
 	Chairman of the Board,
Chief Executive Officer and President  	 	

 

EXHIBIT 31.2
CERTIFICATION PURSUANT TO
RULES 13a-14(a)/15d-14(a)
UNDER THE SECURITIES EXCHANGE
ACT OF 1934, AS AMENDED
I, John C. Molina, J.D., certify that:
1. I have reviewed the report on Form 10-Q for the period ended March 31, 2011 of Molina Healthcare, Inc.;
2. Based on my knowledge, the report does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;
3. Based on my knowledge, the financial statements, and other financial information included in the report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in the report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), and internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended), for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period for which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in the report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by the report based on such evaluation; and
(d) Disclosed in the report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and to the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 	 	 	 	 	
Dated: May 9, 2011 	/s/ John C. Molina, J.D.  	 	
 	John C. Molina, J.D. 	 	
 	Chief Financial Officer and Treasurer 	 	

 

EXHIBIT 32.1
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the report of Molina Healthcare, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2011 (the “Report”), I, Joseph M. Molina, M.D., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 9, 2011 	/s/ Joseph M. Molina, M.D.  	 	
 	Joseph M. Molina, M.D. 	 	
 	Chairman of the Board,
Chief Executive Officer and President  	 	

 

EXHIBIT 32.2
CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the report of Molina Healthcare, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2011 (the “Report”), I, John C. Molina, J.D., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 	 	 	 	 	
Dated: May 9, 2011  	/s/ John C. Molina, J.D.  	 	
 	John C. Molina, J.D. 	 	
 	Chief Financial Officer and Treasurer